Energizer Holdings, Inc. Announces Fiscal 2020 Fourth Quarter and Full Year Results, Financial Outlook for Fiscal 2021 and New Share Repurchase Authorization

– Strong top-line growth with fiscal fourth quarter reported net sales increase of 6.1% due to organic net sales growth and fiscal 2020 reported net sales increase of 10.0%, including 2.5% of organic growth.(1)

– Diluted net loss from continuing operations per common share of $0.67 in the fourth fiscal quarter, and Diluted net earnings from continuing operations per common share of $0.44 in fiscal 2020, and includes loss on debt extinguishment, impact of acquisition and integration costs and higher than expected COVID costs.

– Adjusted Diluted net earnings from continuing operations per common share of $0.59 in the fourth fiscal quarter and Adjusted Diluted net earnings from continuing operations per common share of $2.31 in fiscal 2020, inclusive of $0.28 and $0.41 of incremental COVID-19 costs, respectively.(1)

– Better than expected cash flows from operating activities of $157 million in the fourth fiscal quarter and $389 million for the fiscal year, and Adjusted free cash flow of $161 million in the fourth fiscal quarter and $405 million for the fiscal year, allowing for over $100 million in debt pay down subsequent to year-end.(1)

– Company expects to deliver 2% to 4% organic revenue growth, Adjusted EBITDA in the range of $600 to $630 million and Adjusted earnings per share in the range of $2.95 to $3.25 for fiscal 2021.(1)

– Announces Board approval of new 7.5 million share repurchase authorization.

PR Newswire

ST. LOUIS, Nov. 12, 2020 /PRNewswire/ — Energizer Holdings, Inc. (NYSE: ENR) today announced results for the fourth fiscal quarter and full fiscal year, which ended September 30, 2020. 

“The continued elevated demand for batteries and the recovery of the auto care business resulted in our fifth consecutive year of organic growth.  Throughout the pandemic, our focus has continued to be on the health and safety of our colleagues and meeting the needs of our customers and consumers,” said Alan Hoskins, Chief Executive Officer. “Doing so resulted in higher costs and ultimately lower earnings.  We believe that the value of our relationships with our customers far outweighs these short-term costs.” 

“We have taken action to increase our agility and ability to serve our customers. We expect the increased costs related to COVID-19 will be substantially reduced by the end of the first quarter of fiscal 2021.  The actions we have taken include enhancing our manufacturing network, reorganization of our global product supply structure, and acceleration of our investment in enterprise analytics to drive better, and more timely, decision-making. With these steps well underway, we believe we are back on the path of delivering meaningful growth in 2021 and beyond by improving productivity and taking costs out of the business while continuing to grow the top line through both innovation and strengthening our brands.”

(1)

See Press Release attachments and supplemental schedules for additional information, including the GAAP to Non-GAAP reconciliations.

Top-Line Performance

For the quarter and fiscal year, top-line sales growth continued to be very strong.  Net sales were $763.0 million for the fourth fiscal quarter compared to $719.0 million in the prior year period and $2,744.8 million for the fiscal year compared to $2,494.5 million for the prior fiscal year. 


Fourth
Quarter


% Chg


Full Fiscal
Year


% Chg

Net Sales – FY’19

$

719.0

$

2,494.5

Organic

43.8

6.1

%

61.4

2.5

%

Impact of Battery Acquisition

%

125.5

5.0

%

Impact of Auto Care Acquisition

%

85.1

3.4

%

Change in Argentina operations

2.0

0.3

%

1.6

0.1

%

Impact of currency

(1.8)

(0.3)

%

(23.3)

(1.0)

%

Net Sales – FY’20

$

763.0

6.1

%

$

2,744.8

10.0

%

 

Organic net sales increased 6.1% in the fourth fiscal quarter due to the following items:(1)

  • Distribution gains across all product categories contributed 3% to the organic increase;
  • Increased year-over-year replenishment volume, primarily in North America battery, contributed 3% to the increase;
  • Increased volume driven by the COVID-19 pandemic, which was slightly offset by increased retailer fines and penalties due to the unprecedented demand spike and necessary actions to support our customers and consumers, contributed a net impact of 0.9% to the increase; and
  • Lower year-over-year U.S. hurricane volume of 0.8% partially offset the increases.

Organic net sales increased 2.5% in the fiscal year due to the following items:(1)

  • Distribution gains contributed 2.7% of the increase;
  • Favorable carryover impact of the fiscal 2019 price increases, together with the net COVID-19 pandemic impact driven by North America battery, contributed 1.0% of the increase; and
  • Lower replenishment volume early in the year, and the year-over-year impact of lower storm activity partially offset the increases.

Gross Margin

Gross margin percentage on a reported basis for the fourth fiscal quarter was 36.9%, versus 40.0% in the prior year quarter, and was 39.4% for fiscal 2020, versus 40.2% in the prior year. Excluding the prior year inventory step up resulting from purchase accounting and acquisition and integration costs in both years, gross margin was 38.4% for the fourth fiscal quarter, down 370 basis points from the prior year quarter, and was 40.6% for the fiscal year, down 200 basis points from prior year.(1)


Fourth Quarter


Full Fiscal Year

Adjusted Gross Margin – FY’19 (1)

42.1

%

42.6

%

Incremental COVID-19 costs

(2.3)

%

(1.1)

%

Collective shift in customer and product mix

(1.7)

%

(0.8)

%

Unfavorable movement in foreign currencies and tariffs

(1.0)

%

(0.6)

%

Lower margin rate profile of the acquired businesses

%

(0.8)

%

Synergy realization

1.3

%

1.3

%

Adjusted Gross Margin – FY’20 (1)

38.4

%

40.6

%

 

Gross margin reflects the demand impact from COVID-19 that was elevated and prolonged for much of fiscal 2020 which put significant stress on our global network.  This impact was compounded in the fourth quarter due to preparation for the upcoming holiday season.  In order to serve our customers, we took a series of actions, including higher than normal internal production, aggressively sourcing raw materials and finished goods, and increasing air freight and co-packing capacity. These efforts resulted in incremental COVID-19 costs in the fiscal fourth quarter and fiscal year.

Fiscal 2020 gross margin performance was also heavily impacted by sales mix changes, including:

  • As the fiscal year unfolded, the pandemic resulted in lockdowns across the world, which drove shifts in our business from higher margin markets, which in some cases had longer and more severe lockdowns, to lower margin markets; and
  • Changes in consumers’ shopping behaviors as they navigated the pandemic by migrating to different channels and products.

Selling, General and Administrative expense (SG&A)

SG&A, excluding acquisition and integration costs, for the fourth fiscal quarter was 15.6% of net sales, or $118.8 million, a decrease of $4.2 million versus the prior year.  This decrease was driven by synergy realization primarily due to transition service agreement (TSA) exits.(1)   

SG&A, excluding acquisition and integration costs, for fiscal 2020 was $444.5 million, or 16.2% of net sales, as compared to $433.4 million, or 17.4% of net sales, in the prior year.  The changes were due to incremental SG&A of approximately $26 million due to the Battery and Auto Care Acquisitions, partially offset by synergy realization and reduced spending.(1)  

Advertising and promotion expense (A&P)

A&P was 5.3% of net sales for the fourth fiscal quarter, an increase of 150 basis points, or $12.8 million.  The increase was due to planned incremental investment in our branded product portfolio.

A&P was 5.4% of sales for fiscal 2020, an increase of 30 basis points, or $19.8 million. The increase over prior year is driven by incremental spending of $3.5 million due to the Battery and Auto Care Acquisitions, which was primarily for product and packaging innovation and promotional support for our auto care brands, in addition to planned incremental investment in our branded product portfolio.

 


Earnings Per Share and Adjusted EBITDA


Fourth Quarter


Full Fiscal Year

(In millions, except per share data)

2020

2019

2020

2019

Net (loss)/earnings from continuing operations

$

(41.7)

$

47.0

$

46.8

$

64.7

Diluted net (loss)/earnings per common share – continuing operations

$

(0.67)

$

0.62

$

0.44

$

0.78

Adjusted net earnings from continuing operations(1)

$

44.7

$

68.6

$

176.8

$

216.1

Adjusted diluted net earnings per common share – continuing operations (1)

$

0.59

$

0.93

$

2.31

$

3.00

Adjusted EBITDA(1)

$

140.4

$

156.9

$

562.0

$

545.5

During the quarter, the Company took advantage of favorable debt markets and refinanced its Senior Notes due 2025 and 2026, totaling $1.35 billion in principal amount, with new Senior Notes which come due in 2028 and 2029, respectively.  The new Senior Notes have significantly lower interest rates and will result in approximately $17.5 million in annual interest savings, as well as an extension of the weighted average maturity of these borrowings by roughly three years.

Our fourth quarter earnings per share and Adjusted EBITDA were lower than previously provided guidance primarily due to incremental COVID-19 costs caused by elevated demand, primarily customer fines and penalties, increased product sourcing costs, including tariffs, and higher SG&A relating to factoring costs, legal fees and compensation expenses. These increased costs resulted in a decline of approximately $16 million in Adjusted EBITDA, and coupled with the increase in tax rate, approximately $0.20 of earnings per share for the year.

The Net loss from continuing operations for the fiscal fourth quarter included the loss on the extinguishment of debt of  $90.7 million, or $1.01 per diluted share, and pre-tax acquisition and integration expense of $20.4 million, or $0.29 per diluted share. 

The Net earnings from continuing operations for the fiscal year included the loss on extinguishment of debt of $94.9 million, or $1.05, per diluted share, and pre-tax acquisition and integration costs of $68.0 million, or $0.79 per diluted share.

The change in Adjusted EBITDA and Adjusted diluted net earnings per common share – continuing operations for the quarter was driven in large part by incremental COVID-19 costs, including air freight and customer fines and penalties and increased A&P, offset by the continued realization of synergies. 

The impacts on Adjusted EBITDA and Adjusted diluted net earnings per common share – continuing operations for the fiscal year were largely the same as the fiscal quarter, with the addition of a full year of acquisition activity, as well as the impact of unfavorable currency.  A higher tax rate, due to country mix of earnings, also impacted the year-over-year change in adjusted  earnings per common share – continuing operation.

Incremental COVID-19 Costs

The table below is a summary of the incremental COVID-19 costs incurred for the fourth fiscal quarter and fiscal year in addition to the impact these costs had on our EBITDA and Earnings per share for both periods presented:

 

(In millions, except per share data)


Fourth Quarter


Fiscal Year 2020

Gross margin

$

19.0

$

29.0

SG&A

3.0

Interest expense

3.0

7.0

Incremental COVID-19 Costs

$

25.0

$

36.0

Impact to EBITDA

$

22.0

$

29.0

Impact to Earnings per share

$

0.28

$

0.41

 

Strong Free Cash Flow and Continued Return of Capital

  • We generated strong cash flows from continuing operations of $157.4 million and $389.3 million for the quarter and the year, respectively, and Adjusted Free Cash Flow from continuing operations of $161.4 million and $405.1 million for the quarter and year, respectively, driven primarily by working capital improvements and certain one-time tax items realized earlier in the year. Strong cash flows allowed for the Company to pay down over $100 million of debt subsequent to year-end.(1)
  • Dividend payments in the quarter were approximately $21 million, or $0.30 per common share and $4.1 million, or $1.875 per share of mandatory preferred convertible stock. Dividend payments for the year were $85.4 million, or $1.20 per common share and $16.2 million, or $7.50 per share of mandatory preferred convertible shares.
  • Repurchased approximately 980,000 shares of common stock for $45.0 million in the first fiscal quarter. As noted above, the Board has approved a new share repurchase program for up to 7.5 million shares. This replaced the prior authorization that was outstanding.
  • Net debt to credit defined EBITDA was 4.8 times at the end of fiscal 2020.

Financial Outlook and Assumptions for Fiscal Year 2021(1)

The Company is providing the below financial outlook and assumptions for fiscal 2021. Note that all comparisons are with actual results for fiscal year ended September 30, 2020. As we continue to navigate through the impacts of the pandemic, our assumptions for fiscal 2021 do not anticipate any significant disruptions to our global manufacturing plants, distribution centers or customers. We assume the retail environment will remain competitive and the commodity costs will be benign. Should disruption occur that is prolonged, our expected results may be significantly impacted as we may not be able to supply demand in a timely manner or at all.  Looking specifically at our key metrics for fiscal 2021, we expect the following:

  • Net Sales growth in the range of 2% to 4% with expected growth in batteries at the low end of the range and auto care at the high end of the range;
  • Adjusted gross margin to be essentially flat with approximately $15 million of COVID-19 costs expected to be incurred in the first quarter, and an expected sequential improvement in gross margin rate as we progress through 2021;
  • Adjusted earnings per share in the range of $2.95 to $3.25;
  • Adjusted EBITDA range of $600 to $630 million;
  • Adjusted free cash flow in the range of $325 to $350 million dollars, as working capital returns to more normalized levels and we lapped one-time tax items from the prior fiscal year;
  • Capital spending, excluding integration, in the range of $35 to $45 million, and integration related capital in the range of $30 to $40 million.

Given the expected growth in fiscal 2021 is off lower-than-previously expected fiscal 2020 results and the uncertainty related to the pandemic, the the Company is withdrawing its pre-pandemic targets for 2022 of $700 million in adjusted EBITDA and $400 million in adjusted free cash flow. We have provided additional details on our long-term algorithm in the deck that was provided with the release.

Webcast Information

In conjunction with this announcement, the Company will hold an investor conference call beginning at 10:00 a.m. eastern time today. The call will focus on fourth quarter and fiscal 2020 financial results and the financial outlook for fiscal 2021. All interested parties may access a live webcast of this conference call at www.energizerholdings.com, under “Investors” and “Events and Presentations” tabs or by using the following link:


https://www.webcaster4.com/Webcast/Page/1192/37929

For those unable to participate during the live webcast, a replay will be available on www.energizerholdings.com, under “Investors,” “Events and Presentations,” and “Past Events” tabs.

Forward-Looking Statements.
This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future sales, gross margins, costs, earnings, cash flows, tax rates and performance of the Company. These statements generally can be identified by the use of forward-looking words or phrases such as “believe,” “expect,” “expectation,” “anticipate,” “may,” “could,” “intend,” “belief,” “estimate,” “plan,” “target,” “predict,” “likely,” “should,” “forecast,” “outlook,” or other similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances. Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation:

  • market and economic conditions;
  • market trends in the categories in which we compete;
  • uncertainty relating to the impacts of the COVID-19 outbreak, including but not limited to, its impacts on consumer demand, costs, product mix, the availability of our products, our strategic initiatives, our and our partners’ global supply chains, operations and routes to market;
  • our ability to integrate businesses, to realize the projected results of the acquired businesses, and to obtain expected cost savings, synergies and other anticipated benefits of the acquired businesses within the expected timeframe, or at all;
  • the impact of the acquired businesses on our business operations;
  • the success of new products and the ability to continually develop and market new products;
  • our ability to attract, retain and improve distribution with key customers;
  • our ability to continue planned advertising and other promotional spending;
  • our ability to timely execute strategic initiatives, including restructurings, and international go-to-market changes in a manner that will positively impact our financial condition and results of operations and does not disrupt our business operations;
  • the impact of strategic initiatives, including restructurings, on our relationships with employees, customers and vendors;
  • our ability to maintain and improve market share in the categories in which we operate despite heightened competitive pressure;
  • financial strength of distributors and suppliers;
  • our ability to improve operations and realize cost savings;
  • the impact of the United Kingdom’s future trading relationships following its exit from the European Union;
  • the impact of foreign currency exchange rates and currency controls, as well as offsetting hedges;
  • the impact of adverse or unexpected weather conditions;
  • uncertainty from the expected discontinuance of LIBOR and the transition to any other interest rate benchmark;
  • the impact of raw materials and other commodity costs;
  • the impact of legislative changes or regulatory determinations or changes by federal, state and local, and foreign authorities, including customs and tariff determinations, as well as the impact of potential changes to tax laws, policies and regulations;
  • costs and reputational damage associated with cyber-attacks or information security breaches or other events;
  • the impact of advertising and product liability claims and other litigation; and
  • compliance with debt covenants and maintenance of credit ratings as well as the impact of interest and principal repayment of our existing and any future debt.

In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of any such forward-looking statements. The list of factors above is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include those detailed from time to time in our publicly filed documents, including those described under the heading “Risk Factors” in our Form 10-K filed with the Securities and Exchange Commission on November 19, 2019 as well as our Form 10-Q filed on August 5, 2020.


ENERGIZER HOLDINGS, INC.


CONSOLIDATED STATEMENT OF EARNINGS


(Condensed)


(In millions, except per share data – Unaudited)


Quarter Ended
September 30,


Twelve Months Ended
September 30,


2020


2019


2020


2019

Net sales

$

763.0

$

719.0

$

2,744.8

$

2,494.5

Cost of products sold (1)

481.2

431.2

1,662.9

1,490.7

Gross profit

281.8

287.8

1,081.9

1,003.8

Selling, general and administrative expense (1)

132.3

142.2

483.3

515.7

Advertising and promotion expense

40.2

27.4

147.1

127.3

Research and development expense (1)

9.8

9.1

35.4

32.8

Amortization of intangible assets

14.2

13.1

56.5

43.2

Interest expense (1) (2)

50.2

48.7

195.0

226.0

Loss on extinguishment of debt (3)

90.7

94.9

Other items, net (1)

(3.8)

(0.4)

2.0

(14.3)

(Loss)/Earnings before income taxes

(51.8)

47.7

67.7

73.1

Income tax (benefit)/provision

(10.1)

0.7

20.9

8.4

Net (loss)/earnings from continuing operations

$

(41.7)

$

47.0

$

46.8

$

64.7

Net loss from discontinued operations (4)

(9.8)

(0.8)

(140.1)

(13.6)

Net (loss)/earnings

(51.5)

46.2

(93.3)

51.1

Mandatory preferred stock dividends

(4.1)

(4.3)

(16.2)

(12.0)

Net (loss)/earnings attributable to common shareholders

$

(55.6)

$

41.9

$

(109.5)

$

39.1

Basic net (loss)/earnings per common share – continuing operations

$

(0.67)

$

0.62

$

0.44

$

0.79

Basic net loss per common share – discontinued operations

(0.14)

(0.01)

(2.03)

(0.20)

Basic net (loss)/earnings per common share

$

(0.81)

$

0.61

$

(1.59)

$

0.59

Diluted net (loss)/earnings per common share – continuing operations

$

(0.67)

$

0.62

$

0.44

$

0.78

Diluted net loss per common share – discontinued operations

(0.14)

(0.01)

(2.02)

(0.20)

Diluted net (loss)/earnings per common share

$

(0.81)

$

0.61

$

(1.58)

$

0.58

Weighted average shares of common stock – Basic

68.5

68.9

68.8

66.4

Weighted average shares of common stock – Diluted

68.5

69.2

69.5

67.3

(1)

See the Supplemental Schedules – Non-GAAP Reconciliation attached which breaks out the Acquisition and integration related items included within these lines.

(2)

Includes Acquisition debt commitment fees, interest, and ticking fees of $65.6 million for the twelve months ended September 30, 2019.

(3)

The Loss on the extinguishment of debt for the quarter ended September 30, 2020 relates to the Company’s July 2020 redemption of its $600.0 million Senior Notes due in 2025 and the redemption of the $750.0 million Senior Notes due in 2026 which were redeemed subsequent to year-end on October 16, 2020.  The twelve months ended September 30, 2020 also includes the write off of deferred financing fees related to the term loan refinancing in December 2019.

(4)

Included in these results is the pre-tax loss on the disposition of the Varta consumer battery business of $141.6 million in the twelve months ended September 30, 2020. The Net loss on discontinued operations is net of income tax expense of $5.4 million and a benefit of $1.2 million for the quarter and twelve months ended September 30, 2020, respectively and income tax expense of $6.5 million and $4.0 million for the quarter and twelve months ended September 30, 2019, respectively.

 

 


ENERGIZER HOLDINGS, INC.


CONSOLIDATED BALANCE SHEETS


(Condensed)


(In millions – Unaudited)


SEPTEMBER 30,


2020


2019


Assets

Current assets

Cash and cash equivalents

$

459.8

$

258.5

Restricted cash

790.0

Trade receivables

292.0

340.2

Inventories

511.3

469.3

Other current assets

157.8

177.1

Assets held for sale

791.7

Total current assets

$

2,210.9

$

2,036.8

Property, plant and equipment, net

352.1

362.0

Operating lease asset

121.9

Goodwill

1,016.0

1,004.8

Other intangible assets, net

1,909.0

1,958.9

Deferred tax asset

24.3

22.8

Other assets

94.1

64.3

 Total assets

$

5,728.3

$

5,449.6


Liabilities and Shareholders’ Equity

Current liabilities

Current maturities of long-term debt

$

841.3

$

Current portion of capital leases

1.7

1.6

Notes payable

3.8

31.9

Accounts payable

378.1

299.0

Current operating lease liabilities

14.8

Other current liabilities

408.7

333.6

Liabilities held for sale

402.9

Total current liabilities

$

1,648.4

$

1,069.0

Long-term debt

3,306.9

3,461.6

Operating lease liabilities

111.9

Deferred tax liability

140.4

170.6

Other liabilities

211.6

204.6

 Total liabilities

$

5,419.2

$

4,905.8

Shareholders’ equity

Common stock

0.7

0.7

Mandatory convertible preferred stock

Additional paid-in capital

859.2

870.3

Retained earnings

(66.2)

129.5

Treasury stock

(176.9)

(158.4)

Accumulated other comprehensive loss

(307.7)

(298.3)

Total shareholders’ equity

$

309.1

$

543.8

Total liabilities and shareholders’ equity

$

5,728.3

$

5,449.6

 

 


ENERGIZER HOLDINGS, INC.


CONSOLIDATED STATEMENT OF CASH FLOWS


(Condensed)


(In millions – Unaudited)


FOR THE YEARS ENDED
SEPTEMBER 30,


2020


2019


Cash Flow from Operating Activities

Net loss/(earnings)

$

(93.3)

$

51.1

Loss from discontinued operations

(140.1)

(13.6)

Net earnings from continuing operations

$

46.8

$

64.7

  Adjustments to reconcile net earnings to net cash flow from operations:

Non-cash integration and restructuring charges

17.8

3.0

Depreciation and amortization

111.9

92.8

Deferred income taxes

(34.8)

(33.3)

Share-based compensation expense

24.5

27.1

Loss on extinguishment on debt

94.9

Mandatory transition tax

(0.4)

Inventory step up

36.2

Settlement loss on pension plan terminations

3.7

Non-cash items included in income, net

23.1

(4.2)

Other, net

(7.1)

22.1

  Changes in assets and liabilities used in operations, net of acquisitions

Decrease/(increase) in accounts receivable, net

47.8

(24.9)

Increase in inventories

(39.8)

(15.2)

Decrease/(increase) in other current assets

53.4

(44.3)

Increase in accounts payable

76.2

5.2

(Decrease)/increase in other current liabilities

(25.4)

9.6

Net cash from operating activities from continuing operations

389.3

142.1

Net cash (used by)/from operating activities from discontinued operations

(12.9)

7.4

Net cash from operating activities

376.4

149.5


Cash Flow from Investing Activities

Capital expenditures

(65.3)

(55.1)

Proceeds from sale of assets

6.4

0.2

Acquisitions, net of cash acquired

(5.1)

(2,460.0)

Net cash used by investing activities from continuing operations

(64.0)

(2,514.9)

Net cash from/(used by) investing activities from discontinued operations

280.9

(407.4)

Net cash from/(used by) investing activities

216.9

(2,922.3)


Cash Flow from Financing Activities

Cash proceeds from issuance of debt with original maturities greater than 90 days

2,020.6

1,800.0

Payments on debt with maturities greater than 90 days

(1,393.5)

(529.5)

Net decrease in debt with maturities 90 days or less

(30.2)

(214.1)

Debt issuance costs

(26.5)

(40.1)

Premiums paid on extinguishment of debt

(18.3)

Net proceeds from issuance of mandatory convertible preferred shares

199.5

Net proceeds from issuance of common stock

205.3

Dividends paid on common stock

(85.4)

(83.0)

Dividends paid on mandatory convertible preferred stock

(16.2)

(8.0)

Common stock repurchased

(45.0)

(45.0)

Taxes paid for withheld share-based payments

(11.3)

(8.3)

Net cash from financing activities from continuing operations

394.2

1,276.8

Net cash used by financing activities from discontinued operations

(1.1)

(4.7)

Net cash from financing activities

393.1

1,272.1

Effect of exchange rate changes on cash, cash equivalents and restricted cash

4.9

(9.1)

Net increase/(decrease) in cash, cash equivalents and restricted cash from continuing operations

724.4

(1,105.1)

Net increase/(decrease) in cash, cash equivalents, and restricted cash from discontinued operations

266.9

(404.7)

Net increase/(decrease) in cash, cash equivalents, and restricted cash

991.3

(1,509.8)

Cash, cash equivalents and restricted cash, beginning of period

258.5

1,768.3

Cash, cash equivalents and restricted cash, end of period

$

1,249.8

$

258.5

 

ENERGIZER HOLDINGS, INC.

Supplemental Schedules

Introduction to the Reconciliation of GAAP and Non-GAAP Measures

For the Quarter and Twelve Months ended September 30, 2020

The Company reports its financial results in accordance with accounting principles generally accepted in the U.S. (“GAAP”). However, management believes that certain non-GAAP financial measures provide users with additional meaningful comparisons to the corresponding historical or future period.  These non-GAAP financial measures exclude items that are not reflective of the Company’s on-going operating performance, such as acquisition and integration costs and related items, settlement loss on pension plan terminations, loss on extinguishment of debt, the one-time impact of the CARES Act and the December 2017 Tax Cuts and Jobs Act (2017 tax reform). In addition, these measures help investors to analyze year over year comparability when excluding currency fluctuations, acquisition activity as well as other company initiatives that are not on-going. We believe these non-GAAP financial measures are an enhancement to assist investors in understanding our business and in performing analysis consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or superior to, the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items being adjusted.

We provide the following non-GAAP measures and calculations, as well as the corresponding reconciliation to the closest GAAP measure in the following supplemental schedules:

Segment profit.  This amount represents the operations of our two reportable segments including allocations for shared support functions.  General corporate and other expenses, global marketing expenses, R&D expenses, amortization expense, interest expense, loss on extinguishment of debt, other items, net, and charges related to acquisition and integration and settlement loss on pension plan terminations have all been excluded from segment profit.

Adjusted net earnings from continuing operations and Adjusted Diluted net earnings per common share – continuing operations (EPS).  These measures exclude the impact of the costs related to acquisition and integration, the loss on extinguishment of debt, the settlement loss on pension plan terminations and the one-time impact of the CARES ACT and 2017 tax reform.

Non-GAAP Tax Rate. This is the tax rate when excluding the pre-tax impact of acquisition and integration, the loss on extinguishment of debt, settlement loss on pension plan terminations, as well as the related tax impact for these items, calculated utilizing the statutory rate for where the costs were incurred, as well as the one-time impact of the CARES Act and 2017 tax reform.

Organic.  This is the non-GAAP financial measurement of the change in revenue or segment profit that excludes or otherwise adjusts for the impact of acquisitions, operations in Argentina, and the impact of currency from the changes in foreign currency exchange rates as defined below:

Impact of acquisitions. Energizer completed the Auto Care Acquisition on January 28, 2019 and the Battery Acquisition on January 2, 2019.  These adjustments include the impact the acquisitions’ ongoing operations contributed to each respective income statement caption for the first year’s operations directly after the acquisition date.  This does not include the impact of acquisition and integration costs associated with the acquisitions.

Change in Argentina operations. The Company is presenting separately all changes in sales and segment profit from our Argentina affiliate due to the designation of the economy as highly inflationary as of July 1, 2018.

  Impact of currency. The Company evaluates the operating performance of our Company on a currency neutral basis. The impact of currency is the difference between the value of current year foreign operations at the current period ending USD exchange rate, compared to the value of the current year foreign operations at the prior period ending USD exchange rate.

  Adjusted Comparisons.  Detail for adjusted gross profit, adjusted gross margin, adjusted SG&A, adjusted SG&A as a percent of sales, adjusted R&D, adjusted Interest expense and adjusted Other items, net are also supplemental non-GAAP measure disclosures. These measures exclude the impact of costs related to acquisition and integration.

Free Cash Flow and Adjusted Free Cash Flow. Free Cash Flow is defined as net cash provided by operating activities reduced by capital expenditures, net of the proceeds from asset sales. Adjusted Free Cash Flow is defined as Free Cash Flow excluding the cash payments for acquisition and integration expenses and integration capital expenditures. These expense cash payments are net of the statutory tax benefit associated with the payment.

EBITDA and Adjusted EBITDA. EBITDA is defined as net earnings before income tax provision, interest, Loss on extinguishment of debt and depreciation and amortization.  Adjusted EBITDA further excludes the impact of the costs related to acquisition and integration and share based payments.

 


Energizer Holdings, Inc.

Supplemental Schedules – Segment Information and Supplemental Sales Data

For the Quarter and Twelve Months ended September 30, 2020

Operations for Energizer are managed via two major geographic reportable segments: Americas and International. Energizer’s operating model includes a combination of standalone and shared business functions between the geographic segments, varying by country and region of the world. Energizer applies a fully allocated cost basis, in which shared business functions are allocated between segments. Such allocations are estimates, and do not represent the costs of such services if performed on a standalone basis. Segment sales and profitability for the quarter and twelve months ended September 30, 2020 and 2019, respectively, are presented below:


For the Quarter Ended
September 30,


For the Twelve Months
Ended September 30,


2020


2019


2020


2019


Net Sales

Americas

$

554.9

$

514.6

$

1,971.2

$

1,734.8

International

208.1

204.4

773.6

759.7


Total net sales


$


763.0


$


719.0


$


2,744.8


$


2,494.5


Segment Profit

Americas

$

144.6

$

148.0

$

498.5

$

456.6

International

28.4

42.9

155.8

174.9


Total segment profit


$


173.0


$


190.9


$


654.3


$


631.5

General corporate and other expenses (1)

(29.8)

(33.2)

(103.8)

(111.5)

Global marketing expense (2)

(9.1)

(5.7)

(28.2)

(18.2)

     Research and development expense (3)

(9.7)

(8.3)

(34.1)

(31.7)

Amortization of intangible assets

(14.2)

(13.1)

(56.5)

(43.2)

Acquisition and integration costs (4)

(20.4)

(28.5)

(68.0)

(188.4)

Settlement loss on pension plan terminations (5)

(3.7)

(3.7)

Loss on extinguishment of debt

(90.7)

(94.9)

Interest expense – Adjusted (6)

(50.2)

(48.7)

(195.0)

(160.4)

Other items, net – Adjusted (7)

(0.7)

(2.0)

(6.1)

(1.3)


Total (loss)/earnings before income taxes


$


(51.8)


$


47.7


$


67.7


$


73.1

(1) Of this amount, $2.9 million and $2.3 million were recorded in Cost of products sold and the remainder was recorded in SG&A in the Consolidated (Condensed) Statement of Earnings for the twelve months ended September 30, 2020 and 2019, respectively.

(2) The quarter and twelve months ended September 30, 2020 includes $3.6 million and $12.1 million recorded in SG&A respectively, and $5.5 million and $16.1 million recorded in A&P, respectively, on the Consolidated (Condensed) Statement of Earnings.  The quarter and twelve months ended September 30, 2019 includes $2.3 million and $6.3 million recorded in SG&A respectively, and $3.4 million and $11.9 million recorded in A&P, respectively, on the Consolidated (Condensed) Statement of Earnings.  

(3) Research and development expense for the quarter and twelve months ended September 30, 2020 included $0.1 million and $1.3 million, respectively, and included $0.8 million and $1.1 million for the quarter and twelve months ended September 30, 2019, respectively, of acquisition and integration costs which have been reclassified for purposes of the reconciliation above.

(4) See the Supplemental Schedules – Non-GAAP Reconciliation for where these charges are recorded in unaudited Consolidated (Condensed) Statement of Earnings.

(5) The prior year settlement is related to the termination of the Ireland pension plan which was recorded in Other items, net.

(6) Interest expense for the twelve months ended September 30, 2019 included $65.6 million of Acquisition debt commitment fees, interest and ticking fees which have been reclassified for purposes of the reconciliation above.

(7) See the Supplemental Non-GAAP reconciliation for the Other items, net reconciliation between the reported and adjusted balances.

Supplemental product information is presented below for revenues from external customers:


For the Quarter Ended
September 30,


For the Twelve Months Ended
September 30,


Net Sales


2020


2019


2020


2019

Batteries

$

579.5

$

561.4

$

2,099.8

$

1,959.9

Auto Care

142.7

119.4

513.0

409.3

Lights and Licensing

40.8

38.2

132.0

125.3


Total Net sales


$


763.0


$


719.0


$


2,744.8


$


2,494.5

 

 


Energizer Holdings, Inc.

Supplemental Schedules – GAAP EPS to Adjusted EPS Reconciliation

For the Quarter and Twelve Months ended September 30, 2020

(In millions, except for per share data- Unaudited)

The following tables provide a reconciliation of Net earnings from continuing operations and Diluted net earnings per common share – continuing operations to Adjusted net earnings from continuing operations and Adjusted diluted net earnings per share – continuing operations, which are non-GAAP measures.


For the Quarter Ended
September 30,


For the Twelve Months Ended
September 30,


2020


2019


2020


2019

Net (loss)/earnings attributable to common shareholders

$

(55.6)

$

41.9

$

(109.5)

$

39.1

Mandatory preferred stock dividends

(4.1)

(4.3)

(16.2)

(12.0)

Net (loss)/earnings

(51.5)

46.2

(93.3)

51.1

Net loss from discontinued operations, net of tax

(9.8)

(0.8)

(140.1)

(13.6)

Net (loss)/earnings from continuing operations

$

(41.7)

$

47.0

$

46.8

$

64.7


Pre-tax adjustments

Acquisition and integration (1)

$

20.4

$

28.5

$

68.0

$

188.4

Loss on extinguishment of debt

90.7

94.9

Settlement loss on pension terminations (Other items, net)

3.7

3.7

   Total adjustments, pre-tax

$

111.1

$

32.2

$

162.9

$

192.1


After tax adjustments

Acquisition and integration

$

19.9

$

19.0

$

55.2

$

148.1

Loss on extinguishment of debt

69.8

73.0

Settlement loss on pension plan terminations

3.7

3.7

One-time impact of the CARES Act

(3.3)

1.8

One-time impact of 2017 tax reform

(1.1)

(0.4)

    Total adjustments, after tax

$

86.4

$

21.6

$

130.0

$

151.4

Adjusted net earnings from continuing operations (2)


$


44.7


$


68.6


$


176.8


$


216.1

Diluted net (loss)/earnings per common share – continuing operations

$

(0.67)

$

0.62

$

0.44

$

0.78


Adjustments

Acquisition and integration

0.29

0.26

0.79

2.06

Loss on extinguishment of debt

1.01

1.05

Settlement loss on pension plan terminations

0.05

0.05

One-time impact of the CARES Act

(0.05)

0.03

One-time impact of 2017 tax reform

(0.01)

(0.01)

Impact for diluted share calculation (3)

0.01

0.01

0.12

Adjusted diluted net earnings per diluted common share – continuing operations

$

0.59

$

0.93

$

2.31

$

3.00

Weighted average shares of common stock – Diluted

68.5

69.2

69.5

67.3

Adjusted Weighted average shares of common stock – Diluted (3)

69.4

73.9

69.5

72.0

(1) See Supplemental Schedules – Non-GAAP Reconciliation for where these costs are recorded on the unaudited Consolidated (Condensed) Statement of Earnings.

(2) The Effective tax rate for the quarters ended September 30, 2020 and 2019 for the Adjusted – Non-GAAP Net Earnings and Diluted EPS was 24.6% and 14.1%, respectively, as calculated utilizing the statutory rate for where the costs were incurred.  The effective rate for the twelve months ended September 30, 2020 and 2019 for the Adjusted – Non-GAAP Net Earnings and Diluted EPS was 23.3% and 18.5%, respectively, as calculated utilizing the statutory rate for where the costs were incurred.

(3) For the quarter ended September 30, 2020, the Adjusted Weighted average shares of common stock – Diluted includes the dilutive impact of our outstanding performance shares and restricted stock as they are dilutive to the calculation. For the quarter and twelve months ended September 30, 2019, the Adjusted Weighted average shares of common stock – Diluted is assuming conversion of the preferred shares as those results are more dilutive.  The shares have been adjusted for the 4.7 million share conversion and the preferred dividend has been excluded from the Adjusted net earnings.

 

 


Energizer Holdings, Inc.


Supplemental Schedules – Segment Sales


For the Quarter and Twelve Months Ended September 30, 2020


(In millions, except per share data – Unaudited)


Net Sales



Americas


Q1’20


% Chg


Q2’20


% Chg


Q3’20


% Chg


Q4’20


% Chg


FY ’20


% Chg

Net sales – prior year

$

373.5

$

381.6

$

465.1

$

514.6

$

1,734.8

Organic

(19.0)

(5.1)

%

10.9

2.9

%

33.6

7.2

%

44.3

8.6

%

69.8

4.0

%

Impact of Battery Acquisition

107.1

28.7

%

%

%

%

107.1

6.2

%

Impact of Auto Care Acquisition

52.9

14.2

%

21.1

5.5

%

%

%

74.0

4.3

%

Change in Argentina operations

0.2

0.1

%

(0.7)

(0.2)

%

0.1

%

2.0

0.4

%

1.6

0.1

%

Impact of currency

(0.2)

(0.1)

%

(3.0)

(0.8)

%

(6.9)

(1.4)

%

(6.0)

(1.2)

%

(16.1)

(1.0)

%


Net sales – current year


$


514.5


37.8


%


$


409.9


7.4


%


$


491.9


5.8


%


$


554.9


7.8


%


$


1,971.2


13.6


%



International

Net sales – prior year

$

198.4

$

174.8

$

182.1

$

204.4

$

759.7

Organic

(0.7)

(0.4)

%

4.1

2.3

%

(11.3)

(6.2)

%

(0.5)

(0.2)

%

(8.4)

(1.1)

%

Impact of Battery Acquisition

18.4

9.3

%

%

%

%

18.4

2.4

%

Impact of Auto Care Acquisition

8.5

4.3

%

2.6

1.5

%

%

%

11.1

1.5

%

Impact of currency

(2.3)

(1.2)

%

(4.4)

(2.5)

%

(4.7)

(2.6)

%

4.2

2.0

%

(7.2)

(1.0)

%


Net sales – current year


$


222.3


12.0


%


$


177.1


1.3


%


$


166.1


(8.8)


%


$


208.1


1.8


%


$


773.6


1.8


%



Total Net Sales

Net sales – prior year

$

571.9

$

556.4

$

647.2

$

719.0

$

2,494.5

Organic

(19.7)

(3.4)

%

15.0

2.7

%

22.3

3.4

%

43.8

6.1

%

61.4

2.5

%

Impact of Battery Acquisition

125.5

21.9

%

%

%

%

125.5

5.0

%

Impact of Auto Care Acquisition

61.4

10.7

%

23.7

4.3

%

%

%

85.1

3.4

%

Change in Argentina operations

0.2

%

(0.7)

(0.1)

%

0.1

%

2.0

0.3

%

1.6

0.1

%

Impact of currency

(2.5)

(0.4)

%

(7.4)

(1.4)

%

(11.6)

(1.7)

%

(1.8)

(0.3)

%

(23.3)

(1.0)

%


Net sales – current year


$


736.8


28.8


%


$


587.0


5.5


%


$


658.0


1.7


%


$


763.0


6.1


%


$


2,744.8


10.0


%

 

 


Energizer Holdings, Inc.


Supplemental Schedules – Segment Profit


For the Quarter and Twelve Months Ended September 30, 2020


(In millions, except per share data – Unaudited)


Segment Profit



Americas


Q1’20


% Chg


Q2’20


% Chg


Q3’20


% Chg


Q4’20


% Chg


FY ’20


% Chg

Segment Profit – prior year

$

116.1

$

88.7

$

103.8

$

148.0

$

456.6

Organic

(17.1)

(14.7)

%

8.6

9.7

%

22.8

22.0

%

0.5

0.3

%

14.8

3.2

%

Impact of Battery Acquisition

21.8

18.8

%

%

%

%

21.8

4.8

%

Impact of Auto Care Acquisition

9.1

7.8

%

6.7

7.6

%

%

%

15.8

3.5

%

Change in Argentina operations

(0.6)

(0.5)

%

(0.3)

(0.3)

%

0.4

0.4

%

(0.1)

(0.1)

%

(0.6)

(0.1)

%

Impact of currency

(0.1)

(0.1)

%

(1.9)

(2.2)

%

(4.1)

(4.0)

%

(3.8)

(2.5)

%

(9.9)

(2.2)

%


Segment Profit – current year


$


129.2


11.3


%


$


101.8


14.8


%


$


122.9


18.4


%


$


144.6


(2.3)


%


$


498.5


9.2


%



International

Segment Profit – prior year

$

54.6

$

36.4

$

41.0

$

42.9

$

174.9

Organic

(8.3)

(15.2)

%

6.1

16.8

%

(3.1)

(7.6)

%

(17.1)

(39.9)

%

(22.4)

(12.8)

%

Impact of Battery Acquisition

6.1

11.2

%

%

%

%

6.1

3.5

%

Impact of Auto Care Acquisition

1.0

1.8

%

0.3

0.8

%

%

%

1.3

0.7

%

Impact of currency

(1.2)

(2.2)

%

(2.4)

(6.6)

%

(3.1)

(7.5)

%

2.6

6.1

%

(4.1)

(2.3)

%


Segment Profit – current year


$


52.2


(4.4)


%


$


40.4


11.0


%


$


34.8


(15.1)


%


$


28.4


(33.8)


%


$


155.8


(10.9)


%



Total Segment Profit

Segment Profit – prior year

$

170.7

$

125.1

$

144.8

$

190.9

$

631.5

Organic

(25.4)

(14.9)

%

14.7

11.8

%

19.7

13.6

%

(16.6)

(8.7)

%

(7.6)

(1.2)

%

Impact of Battery Acquisition

27.9

16.3

%

%

%

%

27.9

4.4

%

Impact of Auto Care Acquisition

10.1

5.9

%

7.0

5.6

%

%

%

17.1

2.7

%

Change in Argentina operations

(0.6)

(0.4)

%

(0.3)

(0.2)

%

0.4

0.3

%

(0.1)

(0.1)

%

(0.6)

(0.1)

%

Impact of currency

(1.3)

(0.6)

%

(4.3)

(3.5)

%

(7.2)

(5.0)

%

(1.2)

(0.6)

%

(14.0)

(2.2)

%


Segment Profit – current year


$


181.4


6.3


%


$


142.2


13.7


%


$


157.7


8.9


%


$


173.0


(9.4)


%


$


654.3


3.6


%

 

 


Energizer Holdings, Inc.


Supplemental Schedules – Non-GAAP Reconciliations


For the Quarter and Twelve Months Ended September 30, 2020


(In millions, except per share data – Unaudited)


Gross Profit



Q1’20



Q2’20



Q3’20



Q4’20



Q1’19



Q2’19



Q3’19



Q4’19



2020



2019

Net Sales

$

736.8

$

587.0

$

658.0

$

763.0

$

571.9

$

556.4

$

647.2

$

719.0

$

2,744.8

$

2,494.5

Cost of products sold – adjusted

428.6

343.1

389.3

469.9

296.4

330.5

388.5

416.6

1,630.9

1,432.0


Adjusted Gross Profit


$


308.2


$


243.9


$


268.7


$


293.1


$


275.5


$


225.9


$


258.7


$


302.4


$


1,113.9


$


1,062.5


Adjusted Gross Margin


41.8


%


41.6


%


40.8


%


38.4


%


48.2


%


40.6


%


40.0


%


42.1


%


40.6


%


42.6


%

Acquisition and integration costs

6.9

8.3

5.5

11.3

4.5

5.9

12.1

32.0

22.5

Inventory step up

27.2

6.5

2.5

36.2

Reported Cost of products sold

435.5

351.4

394.8

481.2

296.4

362.2

400.9

431.2

1,662.9

1,490.7


Reported Gross Profit


$


301.3


$


235.6


$


263.2


$


281.8


$


275.5


$


194.2


$


246.3


$


287.8


$


1,081.9


$


1,003.8


Reported Gross Margin

40.9

%

40.1

%

40.0

%

36.9

%

48.2

%

34.9

%

38.1

%

40.0

%

39.4

%

40.2

%


SG&A



Q1’20



Q2’20



Q3’20



Q4’20



Q1’19



Q2’19



Q3’19



Q4’19



2020



2019

Segment SG&A

$

84.1

$

82.4

$

78.5

$

86.8

$

65.8

$

81.4

$

82.8

$

88.2

$

331.8

$

318.2

Corporate SG&A

24.0

23.0

25.2

28.4

18.7

28.6

29.1

32.5

100.6

108.9

Global Marketing

2.9

2.6

3.0

3.6

1.2

2.2

0.6

2.3

12.1

6.3


SG&A Adjusted – subtotal


$


111.0


$


108.0


$


106.7


$


118.8


$


85.7


$


112.2


$


112.5


$


123.0


$


444.5


$


433.4


SG&A Adjusted % of Net Sales


15.1


%


18.4


%


16.2


%


15.6


%


15.0


%


20.2


%


17.4


%


17.1


%


16.2


%


17.4


%

Acquisition and integration costs

11.1

8.1

6.1

13.5

18.9

29.1

15.1

19.2

38.8

82.3


Reported SG&A


$


122.1


$


116.1


$


112.8


$


132.3


$


104.6


$


141.3


$


127.6


$


142.2


$


483.3


$


515.7


Reported SG&A % of Net Sales


16.6


%


19.8


%


17.1


%


17.3


%


18.3


%


25.4


%


19.7


%


19.8


%


17.6


%


20.7


%


Other items, net



Q1’20



Q2’20



Q3’20



Q4’20



Q1’19



Q2’19



Q3’19



Q4’19



2020



2019

Interest income

$

(0.1)

$

(0.1)

$

(0.2)

$

(0.2)

$

(0.3)

$

(0.7)

$

(0.3)

$

(6.4)

$

(0.6)

$

(7.7)

Foreign currency exchange (gain)/loss

(0.4)

5.5

2.9

0.7

(1.1)

3.8

(0.3)

2.8

8.7

5.2

Pension benefit other than service costs

(0.5)

(0.5)

(0.5)

(0.2)

(0.7)

(0.7)

(0.7)

(0.2)

(1.7)

(2.3)

Other

0.1

0.3

(1.1)

0.4

0.3

5.8

(0.3)

6.1


Adjusted Other items, net


(0.9)


5.2


1.1


0.7


(2.1)


2.4


(1.0)


2.0


6.1


1.3

Acquisition foreign currency loss/(gain)

2.2

(9.0)

0.9

(5.5)

2.2

(13.6)

Interest income on restricted cash

(5.8)

(5.8)

Transition services agreement income

(0.3)

(0.1)

(0.4)

(0.1)

(0.1)

(0.7)

(0.6)

(0.9)

(1.4)

Gain on sale of assets

(1.0)

(1.0)

Pre-acquisition insurance proceeds

(4.9)

(4.9)

Other

0.5

1.5

0.5

1.5


Acquisition and integration cost


0.9


(0.1)


(0.4)


(4.5)


(14.8)


1.4


0.2


(6.1)


(4.1)


(19.3)

Settlement loss on pension plan terminations

3.7

3.7


Total Other items, net Reported


$




$


5.1


$


0.7


$


(3.8)


$


(16.9)


$


3.8


$


(0.8)


$


(0.4)


$


2.0


$


(14.3)


Acquisition and integration



Q1’20



Q2’20



Q3’20



Q4’20



Q1’19



Q2’19



Q3’19



Q4’19



2020



2019

Inventory step up (COGS)

$

$

$

$

$

$

27.2

$

6.5

$

2.5

$

$

36.2

Cost of products sold

6.9

8.3

5.5

11.3

4.5

5.9

12.1

32.0

22.5

SG&A

11.1

8.1

6.1

13.5

18.9

29.1

15.1

19.2

38.8

82.3

Research and development

0.4

0.6

0.2

0.1

0.3

0.8

1.3

1.1

Interest expense

32.4

33.2

65.6

Other items, net

0.9

(0.1)

(0.4)

(4.5)

(14.8)

1.4

0.2

(6.1)

(4.1)

(19.3)


Acquisition and integration related items


$


19.3


$


16.9


$


11.4


$


20.4


$


36.5


$


95.4


$


28.0


$


28.5


$


68.0


$


188.4

 

 


Energizer Holdings, Inc.


Supplemental Schedules – Non-GAAP Reconciliations cont.


For the Quarter and Twelve Months Ended September 30, 2020


(In millions, except per share data – Unaudited)


Q1’20


Q2’20


Q3’20


Q4’20


FY 2020

Net earnings/(loss) from continuing operations

$

45.8

$

13.7

$

29.0

$

(41.7)

$

46.8

Income tax provision/(benefit)

12.9

8.2

9.9

(10.1)

20.9


Earnings/(loss) before income taxes


58.7


21.9


38.9


(51.8)


67.7

Interest expense

46.8

47.2

50.8

50.2

195.0

Loss on extinguishment of debt

4.2

90.7

94.9

Depreciation & Amortization

27.6

28.5

28.2

27.6

111.9


EBITDA


137.3


97.6


117.9


116.7


469.5


Adjustments:

Acquisition and integration costs

19.3

16.9

11.4

20.4

68.0

Share-based payments

7.2

8.7

5.3

3.3

24.5


Adjusted EBITDA


$


163.8


$


123.2


$


134.6


$


140.4


$


562.0

 


Free Cash Flow



2020



2019

Net cash from operating activities

$

389.3

$

142.1

Capital expenditures

(65.3)

(55.1)

Proceeds from sale of assets

6.4

0.2


Free Cash Flow – subtotal


$


330.4


$


87.2

Cash paid for acquisition and integration expenses (1)

33.7

159.2

Cash paid for integration related capital expenditures

41.0

9.8


Adjusted Free Cash Flow


$


405.1


$


256.2

(1) These expenses include financing costs, success fees, consulting and legal costs incurred to complete the acquisition, as well as integration costs incurred since the acquisition.

 

 


Energizer Holdings, Inc.


Supplemental Schedules – Non-GAAP Reconciliations cont.


Fiscal 2021 Outlook


(In millions, except per share data – Unaudited)


Fiscal Year 2021 Outlook Reconciliation – Adjusted earnings from continuing operations and Adjusted diluted net earnings per common share – continuing operations (EPS)


(in millions, except per share data)


Net earnings


EPS

Fiscal Year 2021 – GAAP Outlook

$172

to

$198

$2.30

to

$2.69


Impacts:

  Acquisition and integration costs, net of tax benefit

44

to

38

0.65

to

0.56

Fiscal Year 2021 – Adjusted Outlook

$216

to

$236

$2.95

to

$3.25

 


Fiscal Year 2021 Outlook Reconciliation – Adjusted EBITDA


(in millions, except per share data)

Net earnings from continuing operations

$172

to

$198

Income tax provision

38

to

72

Earnings before income taxes

$210

to

$270

Interest expense

190

to

180

Amortization

58

to

56

Depreciation

57

to

54


EBITDA


$515


to


$560


Adjustments:

  Integration costs

60

to

50

  Share-based payments

25

to

20


Adjusted EBITDA


$600


to


$630

 


Fiscal Year 2021 Outlook Reconciliation – Adjusted Free Cash Flow


(in millions, except per share data)


Net cash from operating activities


$325


to


$360

Capital expenditures

80

to

70


Free cash flow


$245


to


$290


Adjustments:

Integration costs

40

to

30

Integration related capital expenditures

40

to

30


Adjusted free cash flow


$325


to


$350

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/energizer-holdings-inc-announces-fiscal-2020-fourth-quarter-and-full-year-results-financial-outlook-for-fiscal-2021-and-new-share-repurchase-authorization-301171693.html

SOURCE Energizer Holdings, Inc.

Meritor Reports Fourth-Quarter and Fiscal Year 2020 Results

PR Newswire

TROY, Mich., Nov. 12, 2020 /PRNewswire/ — Meritor, Inc. (NYSE: MTOR) today announced reported financial results for its fourth quarter and full fiscal year ending Sept. 30, 2020.

Fourth-Quarter Highlights

  • Sales were $758 million
  • Net income attributable to Meritor and net income from continuing operations attributable to Meritor were each $1 million
  • Diluted earnings per share from continuing operations was $0.01
  • Adjusted income from continuing operations attributable to Meritor was $11 million, or $0.15 of adjusted diluted earnings per share
  • Adjusted EBITDA was $60 million
  • Adjusted EBITDA margin was 7.9 percent

Fourth-Quarter Results

For the fourth quarter of fiscal year 2020, Meritor posted sales of $758 million, down $270 million, or approximately 26 percent, from the same period last year. This decrease in sales was driven by lower market volumes primarily due to decreased customer demand as a result of the COVID-19 pandemic.

Net income attributable to Meritor was $1 million, or $0.01 per diluted share, compared to net income attributable to Meritor of $43 million, or $0.51 per diluted share in the prior year. Net income from continuing operations attributable to the company was $1 million, or $0.01 per diluted share, compared to net income from continuing operations attributable to the company of $42 million, or $0.50 per diluted share, in the prior year. Lower net income year over year was driven primarily by lower revenues as a result of lower market volumes due to the COVID-19 pandemic, partially offset by decreased SG&A due to cost reduction actions executed primarily in the second half of the year, reduced incentive compensation costs and operational performance.

Adjusted income from continuing operations attributable to the company in the fourth quarter was $11 million, or $0.15 of adjusted diluted earnings per share, compared with $70 million, or $0.83 of adjusted diluted earnings per share, in the prior year.

Adjusted EBITDA was $60 million, compared to $116 million in the fourth quarter of fiscal year 2019. Adjusted EBITDA margin for the fourth quarter of fiscal year 2020 was 7.9 percent, compared with 11.3 percent in the same period last year. The decrease in adjusted EBITDA year over year was driven primarily by lower revenues as a result of lower market volumes due to the COVID-19 pandemic. The impact from lower revenue was partially offset by cost reduction actions executed primarily in the second half of the year, reduced incentive compensation costs and operational performance.

Cash flow provided by operating activities in the fourth quarter of fiscal year 2020 was $77 million, compared to $62 million in the same period last year. Free cash flow for the fourth quarter of fiscal year 2020 was $37 million, compared to free cash flow of $22 million in the same period last year. The increase in operating cash flow and free cash flow year over year was driven by improved working capital performance and a one-time $48-million cash contribution and loan repayment to fund the Maremont 524(g) Trust made in fiscal year 2019, which did not repeat.

Fourth-Quarter Segment Results

Commercial Truck sales were $560 million in the fourth quarter of fiscal year 2020, down 28 percent compared to the fourth quarter of fiscal year 2019. The decrease in sales was driven by lower volumes primarily due to decreased customer demand as a result of the COVID-19 pandemic.

Commercial Truck segment adjusted EBITDA was $24 million in the fourth quarter of fiscal year 2020, down $48 million from the same period in the prior fiscal year. Segment adjusted EBITDA margin decreased to 4.3 percent from 9.3 percent in the same period of the prior fiscal year. The decrease in segment adjusted EBITDA and segment adjusted EBITDA margin were driven primarily by lower market volumes for most regions due to COVID-19 and higher costs incurred to support electrification initiatives, partially offset by the cost reduction actions, reduced incentive compensation costs and operational performance.

Aftermarket and Industrial sales were $226 million in the fourth quarter of fiscal year 2020, down 22 percent compared to the fourth quarter of fiscal year 2019. The decrease in sales was driven by lower volumes across the segment. Aftermarket sales decreased due to lower customer demand and the impact from the termination of the distribution arrangement with WABCO Holdings, Inc. (“WABCO”), which occurred in the second quarter of fiscal year 2020. Industrial sales also decreased, driven by lower market volumes primarily as a result of the impact of the COVID-19 pandemic.

Segment adjusted EBITDA for Aftermarket and Industrial was $34 million in the fourth quarter of fiscal year 2020, down $7 million from the same period in the prior year. Segment adjusted EBITDA margin increased to 15.0 percent in the fourth quarter of fiscal year 2020, compared to 14.2 percent in the same period of the prior year. The decrease in segment adjusted EBITDA was driven primarily by lower volumes and the impact from the termination of the WABCO distribution arrangement, partially offset by cost reduction actions, reduced incentive compensation costs and operational performance. Segment adjusted EBITDA margin increased due to cost reduction actions that more than offset the volume reductions and impact of the WABCO termination.

Fiscal Year 2020 Results

For fiscal year 2020, Meritor posted sales of $3.0 billion, down $1.3 billion, or approximately 31 percent from the prior year. The decrease in sales was driven by lower market volumes primarily due to decreased customer demand, as a result of the COVID-19 pandemic.

Net income attributable to Meritor was $245 million, or $3.24 per diluted share, compared to $291 million, or $3.37 per diluted share, in the same period last year. Net income from continuing operations attributable to the company was $244 million, or $3.23 per diluted share, compared to net income from continuing operations attributable to the company of $290 million, or $3.36 per diluted share, in the same period last year. Lower net income year over year was driven primarily by lower revenues as a result of significantly reduced market volumes due to the COVID-19 pandemic, as well as higher restructuring costs related to actions taken in fiscal year 2020. This decrease was partially offset by $203 million of after tax income associated with the termination of the company’s distribution arrangement with WABCO in fiscal year 2020.

Adjusted income from continuing operations in fiscal year 2020 was $85 million, or $1.12 per adjusted diluted share, compared to $330 million, or $3.82 per adjusted diluted share, in the prior year. The decrease in adjusted income year over year was driven primarily by lower revenues as a result of reduced market volumes due to the COVID-19 pandemic.

Adjusted EBITDA was $272 million in fiscal year 2020, compared with $520 million in fiscal year 2019. Adjusted EBITDA margin was 8.9 percent in fiscal year 2020, down 300 basis points compared with the prior fiscal year. The decrease in adjusted EBITDA year over year was driven primarily by lower revenues as a result of reduced market volumes due to the COVID-19 pandemic. Cost reduction actions executed primarily in the second half of fiscal year 2020 partially offset the impact from lower revenue.

Cash flow from operating activities in the fiscal year was $265 million, compared to $256 million in fiscal year 2019. Free cash flow for the full fiscal year was $180 million, compared to $153 million in fiscal year 2019. The increase in cash provided by operating activities was driven primarily by $265 million of cash received from the termination of the distribution arrangement with WABCO in fiscal year 2020 and a one-time $48 million cash contribution and loan repayment to fund the Maremont 524(g) Trust made in fiscal year 2019, which did not repeat, largely offset by lower fiscal year 2020 revenues as a result of significantly reduced market volumes primarily due to the impact of the COVID-19 pandemic.

Fiscal Year 2020 Highlights

Capital Return

In fiscal year 2020, the company repurchased 10.4 million shares of common stock for $241 million, representing more than 12 percent of the average shares outstanding at the beginning of the fiscal year.

Advanced Technology Investment

Meritor acquired all the outstanding common shares of Transportation Power, Inc. (“TransPower”) in fiscal year 2020. Through the addition of TransPower’s product portfolio, the company continues to advance its M2022 priorities through increased investment in next-generation electrification technologies, and it further establishes the value of Meritor’s Blue Horizon™ brand across the industry.

Outlook for Fiscal Year 2021

The company is providing the following guidance for fiscal year 2021:

  • Revenue to be in the range of $3.1 billion to $3.35 billion
  • Net income attributable to Meritor and net income from continuing operations attributable to Meritor to be in the range of $45 million to $75 million
  • Diluted earnings per share from continuing operations to be in the range of $0.60 to $1.05
  • Adjusted diluted earnings per share from continuing operations to be in the range of $1.10 to $1.75
  • Adjusted EBITDA margin to be in the range of 9.2 percent to 10.2 percent
  • Operating cash flow to be in the range of $145 million to $185 million
  • Free cash flow to be in the range of $60 million to $100 million

“While fiscal year 2020 brought unforeseen headwinds, Meritor implemented cost containment actions early, bolstered our liquidity and maintained a strong balance sheet, which helped offset the financial impact of the pandemic and enabled us to continue making long-term investments,” said Jay Craig, president and CEO of Meritor. “We remain confident that our M2022 plan remains on track.”

Fourth-Quarter and Fiscal Year 2020 Conference Call

Meritor will host a conference call and webcast to discuss the company’s fourth-quarter and full-year results for fiscal year 2020 on Thursday, Nov. 12 at 9 a.m. ET.

To participate, call (844) 412-1003 within the U.S. or (216) 562-0450 from outside the U.S. at least 10 minutes prior to the start of the call. Please reference conference ID: 7619875 when registering. Investors can also listen to the conference call in real time or access a recording of the call for seven days after the event by visiting the Investors page on meritor.com.

A replay of the call will be available starting at 12 p.m. ET on Nov. 12 until 12 p.m. ET on Nov. 19 by calling (855) 859-2056 within the U.S. or (404) 537-3406 from outside the U.S. Please refer to replay conference ID 7619875. To access the listen-only audio webcast, visit meritor.com and select the webcast link from the Investors page.

About Meritor

Meritor, Inc. is a leading global supplier of drivetrain, mobility, braking and aftermarket solutions for commercial vehicle and industrial markets. With more than a 110-year legacy of providing innovative products that offer superior performance, efficiency and reliability, the company serves commercial truck, trailer, off-highway, defense, specialty and aftermarket customers around the world. Meritor is based in Troy, Mich., United States, and is made up of more than 7,000 diverse employees who apply their knowledge and skills in manufacturing facilities, engineering centers, joint ventures, distribution centers and global offices in 19 countries. Meritor common stock is traded on the New York Stock Exchange under the ticker symbol MTOR. For important information, visit the company’s website at www.meritor.com.

Forward-Looking Statement

This release contains statements relating to future results of the company (including certain outlooks, projections and business trends) that are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by words or phrases such as “believe,” “expect,” “anticipate,” “estimate,” “should,” “are likely to be,” “will” and similar expressions. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to the duration and severity of the COVID-19 pandemic and its effects on public health, the global economy, financial markets and operations; reliance on major OEM customers and possible negative outcomes from contract negotiations with our major customers, including failure to negotiate acceptable terms in contract renewal negotiations and our ability to obtain new customers; the outcome of actual and potential product liability, warranty and recall claims; our ability to successfully manage rapidly changing volumes in the commercial truck markets and work with our customers to manage demand expectations in view of rapid changes in production levels; global economic and market cycles and conditions; availability and sharply rising costs of raw materials, including steel, and our ability to manage or recover such costs; our ability to manage possible adverse effects on European markets or our European operations, or financing arrangements related thereto following the United Kingdom’s decision to exit the European Union or, in the event one or more other countries exit the European monetary union; risks inherent in operating abroad (including foreign currency exchange rates, restrictive government actions regarding trade, implications of foreign regulations relating to pensions and potential disruption of production and supply due to terrorist attacks or acts of aggression); risks related to our joint ventures; rising costs of pension benefits; the ability to achieve the expected benefits of strategic initiatives and restructuring actions; our ability to successfully integrate the products and technologies of Fabco Holdings, Inc., AA Gear Mfg., Inc., AxleTech and Transportation Power, Inc. and future results of such acquisitions, including their generation of revenue and their being accretive; the demand for commercial and specialty vehicles for which we supply products; whether our liquidity will be affected by declining vehicle production in the future; OEM program delays; demand for and market acceptance of new and existing products; successful development and launch of new products; labor relations of our company, our suppliers and customers, including potential disruptions in supply of parts to our facilities or demand for our products due to work stoppages; the financial condition of our suppliers and customers, including potential bankruptcies; possible adverse effects of any future suspension of normal trade credit terms by our suppliers; potential impairment of long-lived assets, including goodwill; potential adjustment of the value of deferred tax assets; competitive product and pricing pressures; the amount of our debt; our ability to continue to comply with covenants in our financing agreements; our ability to access capital markets; credit ratings of our debt; the outcome of existing and any future legal proceedings, including any proceedings or related liabilities with respect to environmental, asbestos-related, or other matters; possible changes in accounting rules; and other substantial costs, risks and uncertainties, including but not limited to those detailed in our Annual Report on Form 10-K for the year ended September 30, 2019 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and from time to time in other filings of the company with the SEC. These forward-looking statements are made only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.

All earnings per share amounts are on a diluted basis. The company’s fiscal year ends on the Sunday nearest Sept. 30, and its fiscal quarters generally end on the Sundays nearest Dec. 31, March 31 and June 30. All year and quarter references relate to the company’s fiscal year and fiscal quarters, unless otherwise stated
.

Non-GAAP Financial Measures

In addition to the results reported in accordance with accounting principles generally accepted in the United States (“GAAP”), we have provided information regarding non-GAAP financial measures. These non-GAAP financial measures include adjusted income (loss) from continuing operations attributable to the company, adjusted diluted earnings (loss) per share from continuing operations, adjusted EBITDA, adjusted EBITDA margin, segment adjusted EBITDA, segment adjusted EBITDA margin, and free cash flow.

Adjusted income (loss) from continuing operations attributable to the company and adjusted diluted earnings (loss) per share from continuing operations are defined as reported income (loss) from continuing operations and reported diluted earnings (loss) per share from continuing operations before restructuring expenses, asset impairment charges, non-cash tax expense, related to the use of deferred tax assets in jurisdictions with net operating loss carry forwards or tax credits, and other special items as determined by management. Adjusted EBITDA is defined as income (loss) from continuing operations before interest, income taxes, depreciation and amortization, non-controlling interests in consolidated joint ventures, loss on sale of receivables, restructuring expenses, asset impairment charges and other special items as determined by management. Adjusted EBITDA margin is defined as adjusted EBITDA divided by consolidated sales from continuing operations. Segment adjusted EBITDA is defined as income (loss) from continuing operations before interest expense, income taxes, depreciation and amortization, noncontrolling interests in consolidated joint ventures, loss on sale of receivables, restructuring expense, asset impairment charges and other special items as determined by management. Segment adjusted EBITDA excludes unallocated legacy and corporate expense (income), net. Segment adjusted EBITDA margin is defined as segment adjusted EBITDA divided by consolidated sales from continuing operations, either in the aggregate or by segment as applicable. Free cash flow is defined as cash flows provided by (used for) operating activities less capital expenditures.

Management believes these non-GAAP financial measures are useful to both management and investors in their analysis of the company’s financial position and results of operations. In particular, adjusted EBITDA, adjusted EBITDA margin, segment adjusted EBITDA, segment adjusted EBITDA margin, adjusted income (loss) from continuing operations attributable to the company and adjusted diluted earnings (loss) per share from continuing operations are meaningful measures of performance to investors as they are commonly utilized to analyze financial performance in our industry, perform analytical comparisons, benchmark performance between periods and measure our performance against externally communicated targets.

Free cash flow is used by investors and management to analyze our ability to service and repay debt and return value directly to shareholders. Free cash flow over adjusted income from continuing operations is a specific financial measure of our M2022 plan used to measure the company’s ability to convert earnings to free cash flow.

Management uses the aforementioned non-GAAP financial measures for planning and forecasting purposes, and segment adjusted EBITDA is also used as the primary basis for the Chief Operating Decision Maker (“CODM”) to evaluate the performance of each of our reportable segments.

Our Board of Directors uses adjusted EBITDA margin, free cash flow, adjusted diluted earnings (loss) per share from continuing operations and free cash flow over adjusted income from continuing operations as key metrics to determine management’s performance under our performance-based compensation plans.

Adjusted income (loss) from continuing operations attributable to the company, adjusted diluted earnings (loss) per share from continuing operations, adjusted EBITDA, adjusted EBITDA margin, segment adjusted EBITDA and segment adjusted EBITDA margin should not be considered a substitute for the reported results prepared in accordance with GAAP and should not be considered as an alternative to net income as an indicator of our financial performance. Free cash flow should not be considered a substitute for cash provided by (used for) operating activities, or other cash flow statement data prepared in accordance with GAAP, or as a measure of financial position or liquidity. In addition, this non-GAAP cash flow measure does not reflect cash used to repay debt or cash received from the divestitures of businesses or sales of other assets and thus does not reflect funds available for investment or other discretionary uses. These non-GAAP financial measures, as determined and presented by the company, may not be comparable to related or similarly titled measures reported by other companies. Set forth below are reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated in accordance with GAAP.

 


MERITOR, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(Unaudited)

(In millions, except per share amounts)


Three Months Ended
September 30,


Twelve Months Ended
September 30,


2020


2019


2020


2019


Sales


$


758


$


1,028


$


3,044


$


4,388


Cost of sales


(699)


(882)


(2,716)


(3,748)


GROSS PROFIT


59


146


328


640


Selling, general and administrative


(40)


(76)


(221)


(256)


Income from WABCO distribution termination






265




Other operating income (expense), net


(8)


(20)


(40)


(21)


OPERATING INCOME


11


50


332


363


Other income, net


10


10


46


40


Equity in earnings of affiliates


3


7


14


31


Interest expense, net


(19)


(14)


(66)


(57)


INCOME BEFORE INCOME TAXES


5


53


326


377


Provision for income taxes


(5)


(13)


(78)


(82)


INCOME FROM CONTINUING OPERATIONS




40


248


295


INCOME FROM DISCONTINUED OPERATIONS, net of tax




1


1


1


NET INCOME




41


249


296


Less: Net loss (income) attributable to noncontrolling interests


1


2


(4)


(5)


NET INCOME ATTRIBUTABLE TO MERITOR, INC.


$


1


$


43


$


245


$


291


NET INCOME ATTRIBUTABLE TO MERITOR, INC.


Net income from continuing operations


$


1


$


42


$


244


$


290


Income from discontinued operations




1


1


1


Net income


$


1


$


43


$


245


$


291


DILUTED EARNINGS PER SHARE


Continuing operations


$


0.01


$


0.50


$


3.23


$


3.36


Discontinued operations




0.01


0.01


0.01


Diluted earnings per share


$


0.01


$


0.51


$


3.24


$


3.37


Diluted average common shares outstanding


73.8


84.1


75.6


86.3

 


MERITOR, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

(in millions)


September 30,
2020


September 30,
2019


ASSETS


CURRENT ASSETS:


Cash and cash equivalents


$


315


$


108


Receivables, trade and other, net


479


551


Inventories


435


526


Other current assets


54


31


TOTAL CURRENT ASSETS


1,283


1,216


NET PROPERTY


515


515


GOODWILL


501


478


OTHER ASSETS


585


606


TOTAL ASSETS


$


2,884


$


2,815


LIABILITIES AND EQUITY


CURRENT LIABILITIES:


Short-term debt


$


39


$


41


Accounts and notes payable


423


610


Other current liabilities


264


285


TOTAL CURRENT LIABILITIES


726


936


LONG-TERM DEBT


1,188


902


RETIREMENT BENEFITS


196


336


OTHER LIABILITIES


279


226


TOTAL LIABILITIES


2,389


2,400


EQUITY:


Common stock (September 30 2020 and 2019, 103.7 and 104.1 shares issued and 72.3 and
81.4 shares outstanding, respectively


105


104


Additional paid-in capital


808


803


Retained Earnings


736


491


Treasury stock, at cost ( September 30, 2020 and September 30, 2019, 31.4 and 22.7 shares,
respectively)


(573)


(332)


Accumulated other comprehensive loss


(614)


(681)


Total equity attributable to Meritor, Inc.


462


385


Noncontrolling interests


33


30


TOTAL EQUITY


495


415


TOTAL LIABILITIES AND EQUITY


$


2,884


$


2,815

 


MERITOR, INC.

ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA-RECONCILIATION

Non-GAAP

AND

CONSOLIDATED BUSINESS SEGMENT SALES INFORMATION

(Unaudited)

(dollars in millions)


Three Months Ended
September 30,


Twelve Months Ended
September 30,


2020


2019


2020


2019


Net income attributable to Meritor, Inc.


$


1


$


43


$


245


$


291


Less: Loss (income) from discontinued operations, net of tax, attributable to
Meritor, Inc.




(1)


(1)


(1)


Income from continuing operations, net of tax, attributable to Meritor, Inc.


$


1


$


42


$


244


$


290


Interest expense, net


19


14


66


57


Provision for income taxes


5


13


78


82


Depreciation and amortization


27


23


101


87


Noncontrolling interests


(1)


(2)


4


5


Loss on sale of receivables


1


1


4


6


Asset impairment charges


8


9


8


10


Income from WABCO distribution termination






(265)




Transaction costs




6


5


6


Asbestos related items








(31)


Restructuring costs




10


27


8


Adjusted EBITDA


$


60


$


116


$


272


$


520


  Adjusted EBITDA margin (1)


7.9


%


11.3


%


8.9


%


11.9


%


Unallocated legacy and corporate expense (income), net (2)


(2)


(3)


(6)


(3)


Segment adjusted EBITDA


$


58


$


113


$


266


$


517


Commercial Truck (3)


Segment adjusted EBITDA


$


24


$


72


$


116


$


342


Segment adjusted EBITDA margin (4)


4.3


%


9.3


%


5.3


%


9.9


%


Aftermarket and Industrial (3)


Segment adjusted EBITDA


$


34


$


41


$


150


$


175


Segment adjusted EBITDA margin (4)


15.0


%


14.2


%


15.3


%


15.9


%


Sales (3)


Commercial Truck


$


560


$


778


$


2,190


$


3,456


Aftermarket and Industrial


226


289


981


1,100


Intersegment Sales


(28)


(39)


(127)


(168)


Total Sales


$


758


$


1,028


$


3,044


$


4,388




(1)



 Adjusted EBITDA margin equals adjusted EBITDA divided by consolidated sales from continuing operations.




(2)



 Unallocated legacy and corporate expense (income), net represents items that are not directly related to the company’s business segments. These items primarily include asbestos-related charges and settlements, pension and retiree medical costs associated with sold businesses, and other legacy costs for environmental and product liability.




(3)



 Amounts for the three and twelve months ended September 30, 2019 have been recast to reflect reportable segment changes.




(4)



 Segment adjusted EBITDA margin equals segment adjusted EBITDA divided by consolidated sales from continuing operations, either in the aggregate or by segment as applicable.

 


MERITOR, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited, in millions)


Twelve Months Ended September 30,


2020


2019


OPERATING ACTIVITIES


Income from continuing operations


$


248


$


295


Adjustments to income from continuing operations to arrive at cash provided by operating activities:


Depreciation and amortization


101


87


Deferred income tax expense


38


40


Restructuring costs


27


8


Equity in earnings of affiliates


(14)


(31)


Asset impairment charges


8


10


Pension and retiree medical income


(42)


(37)


Asbestos related liability remeasurement




(31)


Contribution to Maremont trust




(48)


Other adjustments to income from continuing operations


7


18


Dividends received from equity method investments


10


23


Pension and retiree medical contributions


(15)


(16)


Restructuring payments


(25)


(5)


Changes in off-balance sheet receivable securitization and factoring programs


(77)


(18)


Changes in receivables, inventories and accounts payable


61


(14)


Changes in other current assets and liabilities


(64)


(3)


Changes in other assets and liabilities


2


(22)


Operating cash flows provided by continuing operations


265


256


Operating cash flows used for discontinued operations






CASH PROVIDED BY OPERATING ACTIVITIES


265


256


INVESTING ACTIVITIES


Capital expenditures


(85)


(103)


Cash paid for business acquisitions, net of cash received




(168)


Cash paid for investment in Transportation Power, Inc.


(13)


(6)


Other investing activities


9


6


CASH PROVIDED BY (USED FOR) INVESTING ACTIVITIES


(89)


(271)


FINANCING ACTIVITIES


Securitization


(8)


(38)


Borrowings against revolving line of credit


304


190


Repayments of revolving line of credit


(304)


(190)


Proceeds from debt issuances


300




Term loan borrowings




175


Redemption of notes




(24)


Repayment of notes and term loan


(8)




Debt issuance costs


(5)




Deferred issuance costs




(4)


Other financing activities


(2)


(2)


Net change in debt


277


107


Repurchase of common stock


(241)


(96)


CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES


36


11


EFFECT OF CURRENCY EXCHANGE RATES ON CASH AND CASH EQUIVALENTS


(5)


(3)


CHANGE IN CASH AND CASH EQUIVALENTS


207


(7)


CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR


108


115


CASH AND CASH EQUIVALENTS AT END OF YEAR


$


315


$


108

 


MERITOR, INC.

ADJUSTED INCOME (LOSS) AND EARNINGS (LOSS) PER SHARE — RECONCILIATION

Non-GAAP

(Unaudited)

(in millions, except per share amounts)


Three Months Ended
September 30,


Twelve Months Ended
September 30,


2020


2019


2020


2019


Income from continuing operations attributable to Meritor, Inc.


$


1


$


42


$


244


$


290


Adjustments:


Restructuring costs




10


27


8


Asset impairment charges


8


9


8


10


Non-cash tax expense (1)


3


4


12


51


US. tax reform impacts (2)




6




(3)


Tax valuation allowance reversal, net and other (3)




(3)




(3)


Income tax expense (benefit) (4)


(1)


(4)


54


2


Transaction costs (5)




6


5


6


Income from WABCO distribution termination






(265)




Asbestos related items (6)








(31)


Adjusted income from continuing operations attributable to Meritor, Inc.


$


11


$


70


$


85


$


330


Diluted earnings per share from continuing operations


$


0.01


$


0.50


$


3.23


$


3.36


Impact of adjustments on diluted earnings per share


0.14


0.33


(2.11)


0.46


Adjusted diluted earnings per share from continuing operations


$


0.15


$


0.83


$


1.12


$


3.82


Diluted average common shares outstanding


73.8


84.1


75.6


86.3




(1)



 Represents tax expense including the use of deferred tax assets in jurisdictions with net operating loss carry forwards or tax credits.




(2)



 The three months ended September 30, 2019 includes a one time net charge of $6 million recorded for an election made that will allow for future tax-free repatriation of cash to the United States. The twelve months ended September 30, 2019 includes a one time net charge of $9 million recorded for an election made that will allow for future tax-free repatriation of cash to the United States and $12 million of non-cash tax benefit related to the one time deemed repatriation of accumulated foreign earnings.




(3)



 The three and twelve months ended September 30, 2019 includes a $3 million decrease in valuation allowances for certain U.S. state jurisdictions.




(4)



 The three months ended September 30, 2020 includes $1 million of income tax benefit related to asset impairment. The twelve months ended September 30, 2020 includes $62 million of income tax expense related to the WABCO distribution termination, $6 million of income tax benefits related to restructuring, $1 million of income tax benefits related to asset impairment, and $1 million of income tax benefits related to transaction costs. The three months ended September 30, 2019 includes $2 million of income tax benefits related to restructuring and $2 million related to asset impairment. The twelve months ended September 30, 2019 includes $2 million of income tax benefits related to restructuring, $2 million of income tax benefits related to asset impairment and $6 million of income tax expense related to asbestos related items.




(5)



 Represents transaction fees and inventory step-up amortization.




(6)



 The twelve months ended September 30, 2019 includes $31 million related to the remeasurement of the Maremont net asbestos liability based on the Maremont prepackaged plan of reorganization.

 


MERITOR, INC.

FREE CASH FLOW — RECONCILIATION

Non-GAAP

(Unaudited, in millions)


Three Months Ended
September 30,


Twelve Months Ended
September 30,


2020


2019


2020


2019


Cash provided by operating activities


$


77


$


62


$


265


$


256


Capital expenditures


(40)


(40)


(85)


(103)


Free cash flow


$


37


$


22


$


180


$


153

 


MERITOR, INC.

OUTLOOK FOR FISCAL YEAR 2021— RECONCILIATIONS

Non-GAAP

(Unaudited)

(in millions, except per share amounts)


Fiscal Year


 2021 Outlook (1)


Net income attributable to Meritor, Inc.


$ ~ 45 – 75


Loss from discontinued operations, net of tax, attributable to Meritor, Inc.




Income from continuing operations, net of tax, attributable to Meritor, Inc.


$ ~ 45 – 75


Interest expense, net


~ 80


Provision for income taxes


~ 25 – 50


Depreciation and amortization


~ 100


Restructuring


~ 30


Other (asbestos related liability remeasurement, noncontrolling interests, loss on sale of receivables, etc.)


~ 5 – 7


Adjusted EBITDA


$ ~ 285 – 342


Sales


$ ~ 3,100 – 3,350


Adjusted EBITDA margin (2)


~ 9.2% – 10.2%


Diluted earnings per share from continuing operations


$ ~ 0.60 – 1.05


Adjustments:


Restructuring costs


~ 0.40


Non-cash tax expense (3)


~ 0.10 – 0.30


Adjusted diluted earnings per share from continuing operations


$ ~ 1.10 – 1.75


Diluted average common shares outstanding


~ 73


Cash provided by operating activities


$ ~ 145 – 185


Capital expenditures


~ 85


Free cash flow


$ ~ 60 – 100




(1)



 Amounts are approximate.




(2)



 Adjusted EBITDA margin equals adjusted EBITDA divided by consolidated sales from continuing operations.




(3)



 Represents tax expense related to the use of deferred tax assets in jurisdictions with net operating loss carry forwards or tax credits.

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/meritor-reports-fourth-quarter-and-fiscal-year-2020-results-301171431.html

SOURCE Meritor, Inc.

Urban One, Inc. Reports Third Quarter Results

PR Newswire

WASHINGTON, Nov. 12, 2020 /PRNewswire/ — Urban One, Inc. (NASDAQ: UONEK and UONE) today reported its results for the quarter ended September 30, 2020. Net revenue was approximately $91.9 million, a decrease of 17.2% from the same period in 2019. Broadcast and digital operating income1 was approximately $44.2 million, an increase of 1.3% from the same period in 2019. The Company reported operating income of approximately $4.0 million for the three months ended September 30, 2020, compared to operating income of approximately $31.1 million for the same period in 2019. Net loss was approximately $12.8 million or $0.29 per share (basic) compared to net income of approximately $5.4 million or $0.12 per share (basic) for the same period in 2019. Adjusted EBITDA2 was approximately $39.6 million for the three months ended September 30, 2020, compared to approximately $38.7 million for the same period in 2019.

Alfred C. Liggins, III, Urban One’s CEO and President stated, “During the third quarter, we saw continued sequential improvements in radio revenues: compared to Q2 2020, our radio segment revenues were up 54.3%. This improvement will continue into fourth quarter, where same station radio division revenues are currently pacing down only mid-single digits compared to Q4 2019 including political advertising. Most remarkably, despite the ongoing impact of the Covid-19 pandemic, we were able to grow our Q3 2020 Adjusted EBITDA by 2.3% compared to Q3 2019 and by 61.3% compared to Q2 2020. This was largely driven by impressive performance in our TV, Digital and Reach Media divisions, all of which grew their Adjusted EBITDA by double digit percentages, or better, year-over-year. During this 2020 election cycle we have seen record-breaking political advertising revenues, in excess of $20 million across our entire platform of radio, digital and TV assets. I believe this reflects the increasing recognition of the importance of our audience, and the trusted platform we provide our clients to reach black America. This strong operating performance will push full year 2020 Adjusted EBITDA guidance into the $125$130 million range, which will be a tremendous achievement given the economic impact of Covid-19, and is a testament to the dedication and talent of our staff. Our cash and liquidity position remains robust, with approximately $102.2 million of cash on hand at September 30th. We received strong support from lenders for our recent bond exchange offer, which extends the maturity of both our secured notes and unsecured term loan, thereby giving the Company more flexibility to opportunistically access capital markets during the course of 2021. As part of the exchange agreement we will also reduce our outstanding debt by $25 million. We expect year-end 2020 net leverage to be in the range of 6-1-6.3x, which is lower than where we began the year. We recently announced an exchange of radio assets with Entercom Communications Corp, which, combined with the sale of WFUN St. Louis to Gateway Creative Broadcasting for $8 million, will conservatively add over $1 million of pro-forma BCF. We will now have a formidable radio cluster in Charlotte, NC and I am very excited about our prospects in that market.”



RESULTS OF OPERATIONS

Three Months Ended September 30,

Nine Months Ended September 30,

2020

2019

2020

2019

STATEMENT OF OPERATIONS


(unaudited)


(unaudited)


(in thousands, except share data)


(in thousands, except share data)

NET REVENUE

$                             91,912

$                         111,055

$                  262,795

$                        331,075

OPERATING EXPENSES

Programming and technical, excluding stock-based compensation

24,202

31,037

75,684

93,779

Selling, general and administrative, excluding stock-based compensation

23,516

36,374

75,109

115,174

Corporate selling, general and administrative, excluding stock-based compensation

7,893

8,053

23,365

26,245

Stock-based compensation

794

1,881

1,455

2,592

Depreciation and amortization 

2,489

2,593

7,419

14,451

Impairment of long-lived assets

29,050

82,700

3,800

Total operating expenses 

87,944

79,938

265,732

256,041

             Operating income (loss) 

3,968

31,117

(2,937)

75,034

INTEREST INCOME

178

45

212

131

INTEREST EXPENSE

18,243

20,239

55,776

61,647

OTHER INCOME, net

(1,684)

(1,299)

(3,282)

(4,669)

              (Loss) income before (benefit from) provision for income taxes 
               and noncontrolling interest in income of subsidiaries 

(12,413)

12,222

(55,219)

18,187

(BENEFIT FROM) PROVISION FOR INCOME TAXES

(136)

6,535

(21,526)

8,342

CONSOLIDATED NET (LOSS) INCOME

(12,277)

5,687

(33,693)

9,845

NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

495

328

846

999

CONSOLIDATED NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS

$                           (12,772)

$                             5,359

$                  (34,539)

$                            8,846

AMOUNTS ATTRIBUTABLE TO COMMON STOCKHOLDERS

CONSOLIDATED NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS

$                           (12,772)

$                             5,359

$                  (34,539)

$                            8,846

Weighted average shares outstanding – basic3

44,175,385

44,315,077

44,738,635

44,912,673

Weighted average shares outstanding – diluted4

44,175,385

46,118,702

44,738,635

46,965,245

 

 

Three Months Ended September 30, 

Nine Months Ended September 30, 

2020

2019

2020

2019

PER SHARE DATA – basic and diluted:


(unaudited)


(unaudited)


(unaudited)


(unaudited)


(in thousands, except per share data)


(in thousands, except per share data)

    Consolidated net (loss) income attributable to common stockholders (basic)

$                        (0.29)

$                        0.12

$                    (0.77)

$                          0.20

    Consolidated net (loss) income attributable to common stockholders (diluted)

$                        (0.29)

$                        0.12

$                    (0.77)

$                          0.19

SELECTED OTHER DATA

     Broadcast and digital operating income 1

$                      44,194

$                    43,644

$                112,002

$                    122,122

     Broadcast and digital operating income margin (% of net revenue)

48.1%

39.3%

42.6%

36.9%


Broadcast and digital operating income reconciliation:

    Consolidated net (loss) income attributable to common stockholders

$                    (12,772)

$                      5,359

$                (34,539)

$                        8,846

    Add back non-broadcast and digital operating income items included in consolidated net
(loss) income:

     Interest income

(178)

(45)

(212)

(131)

     Interest expense

18,243

20,239

55,776

61,647

     (Benefit from) provision for income taxes

(136)

6,535

(21,526)

8,342

     Corporate selling, general and administrative expenses

7,893

8,053

23,365

26,245

     Stock-based compensation

794

1,881

1,455

2,592

     Other income, net

(1,684)

(1,299)

(3,282)

(4,669)

     Depreciation and amortization

2,489

2,593

7,419

14,451

     Noncontrolling interest in income of subsidiaries

495

328

846

999

     Impairment of long-lived assets

29,050

82,700

3,800

     Broadcast and digital operating income

$                      44,194

$                    43,644

$                112,002

$                    122,122

Adjusted EBITDA2

$                      39,568

$                    38,671

$                  96,365

$                    106,017


Adjusted EBITDA reconciliation:

Consolidated net (loss) income attributable to common stockholders

$                    (12,772)

$                      5,359

$                (34,539)

$                        8,846

     Interest income

(178)

(45)

(212)

(131)

     Interest expense

18,243

20,239

55,776

61,647

     (Benefit from) provision for income taxes

(136)

6,535

(21,526)

8,342

     Depreciation and amortization

2,489

2,593

7,419

14,451

     EBITDA

$                        7,646

$                    34,681

$                    6,918

$                      93,155

     Stock-based compensation

794

1,881

1,455

2,592

     Other income, net

(1,684)

(1,299)

(3,282)

(4,669)

     Noncontrolling interest in income of subsidiaries

495

328

846

999

     Employment Agreement Award, incentive plan award expenses and other compensation

1,008

860

2,318

3,576

     Contingent consideration from acquisition

5

53

(1)

219

     Severance-related costs

559

358

2,145

1,178

     Cost method investment income from MGM National Harbor

1,695

1,809

3,266

5,167

     Impairment of long-lived assets

29,050

82,700

3,800

     Adjusted EBITDA

$                      39,568

$                    38,671

$                  96,365

$                    106,017

 

 

September 30, 2020

December 31, 2019


(unaudited) 


(in thousands)

SELECTED BALANCE SHEET DATA:

Cash and cash equivalents and restricted cash

$                  102,696

$                   33,546

Intangible assets, net

795,856

881,708

Total assets

1,210,537

1,249,919

Total debt (including current portion, net of original issue discount and issuance costs)

877,125

876,253

Total liabilities

1,036,995

1,056,280

Total stockholders’ equity

162,425

183,075

Redeemable noncontrolling interest

11,117

10,564

September 30, 2020

Applicable Interest Rate


(in thousands)

SELECTED LEVERAGE DATA:

2017 Credit Facility, net of original issue discount and issuance costs of approximately $4.2 million (subject to variable rates) (a)

$                  313,923

5.00%

7.375% senior secured notes due April 2022, net of original issue discount and issuance costs of approximately $1.7 million (fixed rate)

348,315

7.375%

2018 Credit Facility, net of original issue discount and issuance costs of approximately $2.9 million (fixed rate)

131,789

12.875%

MGM National Harbor Loan, net of original issue discount and issuance costs of approximately $1.7 million (fixed rate)

55,598

11.00%

Asset-backed credit facility (subject to variable rates) (a)

27,500

2.40%


(a) 

Subject to variable Libor or Prime plus a spread that is incorporated into the applicable interest rate set forth above.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements represent management’s current expectations and are based upon information available to Urban One at the time of this release. These forward-looking statements involve known and unknown risks, uncertainties and other factors, some of which are beyond Urban One’s control, that may cause the actual results to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.  Important factors that could cause actual results to differ materially are described in Urban One’s reports on Forms 10-K, 10-Q, 10-Q/A, 8-K and other filings with the Securities and Exchange Commission (the “SEC”). Urban One does not undertake any duty to update any forward-looking statements.

Beginning in March 2020, the Company noted that the COVID-19 pandemic and the resulting government stay at home orders across the markets in which we operate were dramatically impacting certain of the Company’s revenues. Most notably, a number of advertisers across significant advertising categories have reduced or ceased advertising spend due to the outbreak and stay at home orders which effectively shut many businesses down.  This has been particularly true within our radio segment which derives substantial revenue from local advertisers who have been particularly hard hit due to social distancing and government interventions. Further, the COVID-19 outbreak has caused the postponement of our 2020 Tom Joyner Foundation Fantastic Voyage cruise and impaired ticket sales of other tent pole special events, some of which we had to cancel. We do not carry business interruption insurance to compensate us for losses that may occur as a result of any of these interruptions and continued impacts from the COVID-19 outbreak. Continued or future outbreaks and/or the speed at which businesses reopen (or reclose) in the markets in which we operate could have material impacts on our liquidity and/or operations including causing potential impairment of assets and of our financial results.

Net revenue consists of gross revenue, net of local and national agency and outside sales representative commissions. Agency and outside sales representative commissions are calculated based on a stated percentage applied to gross billing.


Three Months Ended September 30,


2020


2019


$ Change


% Change

  (Unaudited)


(in thousands)

Net Revenue:

Radio Advertising

$

34,919

$

50,813

$

(15,894)

-31.3%

Political Advertising

4,324

300

4,024

1341.3%

Digital Advertising

8,121

8,171

(50)

-0.6%

Cable Television Advertising

19,603

20,649

(1,046)

-5.1%

Cable Television Affiliate Fees

24,421

25,330

(909)

-3.6%

Event Revenues & Other

524

5,792

(5,268)

-91.0%

Net Revenue (as reported)

$

91,912

$

111,055

$

(19,143)

-17.2%

Net revenue decreased to approximately $91.9 million for the quarter ended September 30, 2020, from approximately $111.1 million for the same period in 2019. The decrease in net revenue was due primarily to the COVID-19 pandemic which continued to weaken demand for advertising in general, impaired ticket sales and caused the postponement or cancellation of major tent pole special events. Net revenues from our radio broadcasting segment decreased 31.9% compared to the same period in 2019. Based on reports prepared by the independent accounting firm Miller, Kaplan, Arase & Co., LLP (“Miller Kaplan“), the markets we operate in (excluding Richmond and Raleigh, both of which no longer participate in Miller Kaplan) decreased 30.0% in total revenues. With the exception of our Philadelphia market, we experienced net revenue declines in all of our radio markets for the quarter, primarily due to lower advertising sales. We recognized approximately $44.7 million of revenue from our cable television segment during the three months ended September 30, 2020, compared to approximately $46.0 million for the same period in 2019 due to decreases in both advertising and affiliate sales. Net revenue from our Reach Media segment decreased approximately $3.2 million for the quarter ended September 30, 2020, compared to the same period in 2019 due primarily to the cancellation of special events. Finally, net revenues for our digital segment increased $281,000 for the three months ended September 30, 2020, compared to the same period in 2019.

Operating expenses, excluding depreciation and amortization, stock-based compensation and impairment of long-lived assets, decreased to approximately $55.6 million for the quarter ended September 30, 2020, down 26.3% from the approximately $75.5 million incurred for the comparable quarter in 2019. The overall operating expense decrease was driven by lower programming and technical expenses, lower selling, general and administrative expenses and lower corporate selling, general and administrative expenses across all of our divisions. Due to COVID-19, all special events scheduled to take place during the quarter were either cancelled or postponed to a later date, for a savings in special events expense of approximately $4.6 million.

During the quarter ended September 30, 2020, we saved approximately $6.8 million in employee compensation expense reductions through a combination of layoffs, furloughs and pay cuts. We have also incurred savings of approximately $1.0 million in reduced or delayed marketing spend, $2.6 million in lower programming content amortization, $1.6 million in contract labor, talent costs and consulting/professional fees and $1.4 million in reduced travel and office expenses.  In addition, there were lower variable expenses such as commissions and rep fees, traffic acquisition costs and music license fees of approximately $1.8 million.

Depreciation and amortization expense decreased to approximately $2.5 million for the quarter ended September 30, 2020, compared to approximately $2.6 million for the same quarter in 2019.

Interest expense decreased to approximately $18.2 million for the quarter ended September 30, 2020, compared to approximately $20.2 million for the same period in 2019. The Company made cash interest payments of approximately $9.2 million on its outstanding debt for the quarter September 30, 2020, compared to cash interest payments of approximately $11.7 million on its outstanding debt for the quarter ended September 30, 2019. As of September 30, 2020, the Company had approximately $27.5 million in borrowings outstanding on its ABL Facility.

The impairment of long-lived assets for the three months ended September 30, 2020, was related to a non-cash impairment charge of approximately $10.0 million recorded to reduce the carrying value of our Atlanta and Indianapolis market goodwill balances and a charge of approximately $19.1 million associated with our Atlanta, Cincinnati, Dallas, Houston, Indianapolis, Philadelphia and Raleigh radio market broadcasting licenses. 

During the three months ended September 30, 2020, the benefit from income taxes was $136,000 compared to the provision for income taxes approximately $6.5 million for the three months ended September 30, 2019. The decrease in the provision for income taxes was primarily due to the application of the actual effective tax rate for the year to date and a pre-tax loss of approximately $12.4 million during the quarter. For the three months ended September 30, 2019, we recorded a provision for income taxes of approximately $6.5 million on pre-tax income from continuing operations of approximately $12.2 million, which results in a tax rate of 53.5%. The tax rate for the third quarter of 2019 is based on an estimated annual effective tax rate of 35.5%, and discrete tax provision adjustments of approximately $1.9 million primarily due to provision to return adjustments related to state apportionment.  The tax provision resulted in an effective tax rate of 1.1% and 53.5% for the three months ended September 30, 2020 and 2019, respectively. The Company paid $509,000 and $458,000 in taxes for the quarters ended September 30, 2020 and 2019, respectively.

Other income, net, was approximately $1.7 million and approximately $1.3 million for the three months ended September 30, 2020 and 2019, respectively. We recognized other income in the amount of approximately $1.7 million and $1.8 million for the three months ended September 30, 2020 and 2019, respectively, related to our MGM investment. We recognized a loss of $509,000 for the three months ended September 30, 2019 related to the sale of its remaining Detroit station and translators.

The increase in noncontrolling interests in income of subsidiaries was due primarily to higher net income recognized by Reach Media during the three months ended September 30, 2020 compared to the three months ended September 30, 2019.

Other pertinent financial information includes capital expenditures of $526,000 and approximately $1.8 million for the quarters ended September 30, 2020 and 2019, respectively. 

During the three months ended September 30, 2020, the Company did not repurchase any shares of Class A or Class D common stock. During the three months ended September 30, 2019, the Company repurchased 6,345 shares of Class A common stock in the amount of $14,000 and repurchased 448,742 shares of Class D common stock in the amount of $975,000.  

The Company, in connection with its prior 2009 stock option and restricted stock plan and its current 2019 Equity and Performance Incentive Plan (the “2019 Plan”), is authorized to purchase shares of Class D common stock to satisfy employee tax obligations in connection with the vesting of share grants under the plan. During the three months ended September 30, 2020, the Company executed a Stock Vest Tax Repurchase of 3,195 shares of Class D Common Stock in the amount of $6,000. During the three months ended September 30, 2019, the Company executed a Stock Vest Tax Repurchase of 13,264 shares of Class D Common Stock in the amount of $25,000.

On August 18, 2020, the Company entered into an Open Market Sales Agreement with Jefferies LLC (“Jefferies”) under which the Company may offer and sell, from time to time at its sole discretion, (the “Current ATM Program”) shares of its Class A common stock, par value $0.001 per share (the “Class A Shares”) up to an aggregate offering price of $25 million. Jefferies is acting as sales agent for the Current ATM Program. In August 2020, the Company issued 2,859,276 shares of its Class A Shares at a weighted average price of $5.39 for approximately $14.8 million of net proceeds after associated fees and expenses. While the Company still has Class A Shares available for issuance under the Current ATM Program, the Company may also enter into new additional ATM programs and issue additional common stock from time to time under those programs.

On October 2, 2020, a private offer to certain eligible noteholders to exchange (the “Exchange Offer”) any and all of its outstanding $350.0 million aggregate principal amount of 7.375% Senior Secured Notes due 2022 (the “Existing Notes”) for newly issued 8.75% Senior Secured Notes due 2022 (the “New Notes”) commenced. As of the expiration date, October 30, 2020, an aggregate of $347.0 million principal amount of Existing Notes were validly tendered and not validly withdrawn. Eligible holders who validly tendered and did not validly withdraw their Existing Notes received the early participation payments and accrued and unpaid interest in cash on their Existing Notes accepted for exchange to, but not including, the Settlement Date for the Exchange Offer. In connection with the settlement of the Exchange Offer and Consent Solicitation, on November 9, 2020, the Company issued $347,016,000 aggregate principal amount of the New Notes.

Supplemental Financial Information:
For comparative purposes, the following more detailed, unaudited statements of operations for the three and nine months ended September 30, 2020 and 2019 are included.

Three Months Ended September 30, 2020


(in thousands, unaudited)

Radio  

Reach

Cable

Corporate/

Consolidated

Broadcasting

Media

Digital

Television

Eliminations

STATEMENT OF OPERATIONS:

NET REVENUE

$

91,912

$

31,645

$

7,751

$

8,451

$

44,746

$

(681)

OPERATING EXPENSES:

Programming and technical 

24,202

8,128

2,758

2,340

11,343

(367)

Selling, general and administrative

23,516

12,137

1,271

4,514

5,870

(276)

Corporate selling, general and administrative

7,893

603

6

1,207

6,077

Stock-based compensation

794

103

691

Depreciation and amortization

2,489

759

59

483

934

254

Impairment of long-lived assets

29,050

29,050

Total operating expenses

87,944

50,177

4,691

7,343

19,354

6,379

           Operating income (loss)

3,968

(18,532)

3,060

1,108

25,392

(7,060)

INTEREST INCOME

178

178

INTEREST EXPENSE

18,243

79

1,919

16,245

OTHER INCOME, net

(1,684)

(1,684)

(Loss) income before (benefit from) provision for income taxes and noncontrolling interest in income of subsidiaries 

(12,413)

(18,532)

3,060

1,029

23,651

(21,621)

(BENEFIT FROM) PROVISION FOR INCOME TAXES

(136)

(1,820)

746

5,931

(4,993)

CONSOLIDATED NET (LOSS) INCOME 

(12,277)

(16,712)

2,314

1,029

17,720

(16,628)

NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

495

495

NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS

$

(12,772)

$

(16,712)

$

2,314

$

1,029

$

17,720

$

(17,123)

Adjusted EBITDA2

$

39,568

$

11,743

$

3,221

$

1,574

$

26,360

$

(3,330)

 

 

Three Months Ended September 30, 2019


(in thousands, unaudited)

Radio  

Reach

Cable

Corporate/

Consolidated

Broadcasting

Media

Digital

Television

Eliminations

STATEMENT OF OPERATIONS:

NET REVENUE

$

111,055

$

46,467

$

10,917

$

8,170

$

45,981

$

(480)

OPERATING EXPENSES:

Programming and technical 

31,037

10,240

4,070

2,899

14,268

(440)

Selling, general and administrative

36,374

19,274

4,411

4,619

8,177

(107)

Corporate selling, general and administrative

8,053

518

1

1,476

6,058

Stock-based compensation

1,881

262

12

11

1,596

Depreciation and amortization

2,593

791

60

474

953

315

Total operating expenses

79,938

30,567

9,071

8,004

24,874

7,422

           Operating income (loss) 

31,117

15,900

1,846

166

21,107

(7,902)

INTEREST INCOME

45

45

INTEREST EXPENSE

20,239

337

1,919

17,983

OTHER (INCOME) EXPENSE, net

(1,299)

515

(1,814)

Income (loss) before provision for (benefit from) income taxes and noncontrolling interest in income of subsidiaries 

12,222

15,048

1,846

166

19,188

(24,026)

PROVISION FOR (BENEFIT FROM) INCOME TAXES

6,535

3,869

485

(13)

4,892

(2,698)

CONSOLIDATED NET INCOME (LOSS) 

5,687

11,179

1,361

179

14,296

(21,328)

NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

328

328

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS

$

5,359

$

11,179

$

1,361

$

179

$

14,296

$

(21,656)

Adjusted EBITDA2

$

38,671

$

17,116

$

1,918

$

710

$

22,101

$

(3,174)

 

 

Nine Months Ended September 30, 2020


(in thousands, unaudited)

Radio  

Reach

Cable

Corporate/

Consolidated

Broadcasting

Media

Digital

Television

Eliminations

STATEMENT OF OPERATIONS:

NET REVENUE

$

262,795

$

87,066

$

20,709

$

20,844

$

136,003

$

(1,827)

OPERATING EXPENSES:

Programming and technical 

75,684

25,604

9,144

7,902

34,163

(1,129)

Selling, general and administrative

75,109

41,555

4,324

11,845

18,022

(637)

Corporate selling, general and administrative

23,365

1,941

25

3,587

17,812

Stock-based compensation

1,455

214

59

6

1,176

Depreciation and amortization

7,419

2,266

178

1,248

2,817

910

Impairment of long-lived assets

82,700

82,700

Total operating expenses

265,732

152,339

15,646

21,026

58,589

18,132

           Operating (loss) income 

(2,937)

(65,273)

5,063

(182)

77,414

(19,959)

INTEREST INCOME

212

178

34

INTEREST EXPENSE

55,776

3

238

5,756

49,779

OTHER INCOME, net

(3,282)

(1)

(3,281)

(Loss) income before (benefit from) provision for income taxes and noncontrolling interest in income of subsidiaries 

(55,219)

(65,275)

5,063

(420)

71,836

(66,423)

(BENEFIT FROM) PROVISION FOR INCOME TAXES

(21,526)

(11,693)

1,320

17,972

(29,125)

CONSOLIDATED NET (LOSS) INCOME 

(33,693)

(53,582)

3,743

(420)

53,864

(37,298)

NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

846

846

NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS

$

(34,539)

$

(53,582)

$

3,743

$

(420)

$

53,864

$

(38,144)

Adjusted EBITDA2

$

96,365

$

21,307

$

5,601

$

1,283

$

80,335

$

(12,161)

 

 

Nine Months Ended September 30, 2019


(in thousands, unaudited)

Radio  

Reach

Cable

Corporate/

Consolidated

Broadcasting

Media

Digital

Television

Eliminations

STATEMENT OF OPERATIONS:

NET REVENUE

$

331,075

$

132,528

$

36,660

$

23,280

$

140,234

$

(1,627)

OPERATING EXPENSES:

Programming and technical 

93,779

31,131

12,150

8,438

43,417

(1,357)

Selling, general and administrative

115,174

57,561

16,712

13,831

27,241

(171)

Corporate selling, general and administrative

26,245

2,062

2

4,617

19,564

Stock-based compensation

2,592

450

31

39

9

2,063

Depreciation and amortization

14,451

2,510

178

1,395

9,430

938

Impairment of long-lived assets

3,800

3,800

Total operating expenses

256,041

95,452

31,133

23,705

84,714

21,037

           Operating income (loss) 

75,034

37,076

5,527

(425)

55,520

(22,664)

INTEREST INCOME

131

131

INTEREST EXPENSE

61,647

1,012

5,757

54,878

OTHER (INCOME) EXPENSE, net

(4,669)

517

(5,186)

Income (loss) before provision for (benefit from) income taxes and noncontrolling interest in income of subsidiaries 

18,187

35,547

5,527

(425)

49,763

(72,225)

PROVISION FOR (BENEFIT FROM) INCOME TAXES

8,342

9,121

1,343

(10)

12,559

(14,671)

CONSOLIDATED NET INCOME (LOSS) 

9,845

26,426

4,184

(415)

37,204

(57,554)

NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS

999

999

NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS

$

8,846

$

26,426

$

4,184

$

(415)

$

37,204

$

(58,553)

Adjusted EBITDA2

$

106,017

$

44,301

$

5,754

$

1,459

$

65,125

$

(10,622)

Urban One, Inc. will hold a conference call to discuss its results for the third fiscal quarter of 2020. The conference call is scheduled for Thursday, November 12, 2020 at 10:00 a.m. EST. To participate on this call, U.S. callers may dial toll-free 1-877-226-8152; international callers may dial direct (+1) 234-720-6982. The Access Code is 163684.

A replay of the conference call will be available from 1:00 p.m. ESTNovember 12, 2020 until 12:00 a.m. ESTNovember 15, 2020. Callers may access the replay by calling 1-866-207-1041; international callers may dial direct (+1) 402-970-0847. The replay Access Code is 8586903.

Access to live audio and a replay of the conference call will also be available on Urban One’s corporate website at www.urban1.com. The replay will be made available on the website for seven days after the call.

Urban One, Inc. (urban1.com), together with its subsidiaries, is the largest diversified media company that primarily targets Black Americans and urban consumers in the United States. The Company owns TV One, LLC (tvone.tv), a television network serving more than 59 million households, offering a broad range of original programming, classic series and movies designed to entertain, inform and inspire a diverse audience of adult Black viewers. As of October 2020, Urban One currently owns and/or operates 61 broadcast stations (including all HD stations, translator stations and the low power television stations we operate) branded under the tradename “Radio One” in 14 urban markets in the United States. Through its controlling interest in Reach Media, Inc. (blackamericaweb.com), the Company also operates syndicated programming including the Rickey Smiley Morning Show, the Russ Parr Morning Show and the DL Hughley Show. In addition to its radio and television broadcast assets, Urban One owns iOne Digital (ionedigital.com), our wholly owned digital platform serving the African-American community through social content, news, information, and entertainment websites, including its Cassius, Bossip, HipHopWired and MadameNoire digital platforms and brands. We also have invested in a minority ownership interest in MGM National Harbor, a gaming resort located in Prince George’s County, Maryland. Through our national multi-media operations, we provide advertisers with a unique and powerful delivery mechanism to the African-American and urban audiences.

Notes:

1              “Broadcast and digital operating income” consists of net (loss) income before depreciation and amortization, corporate selling, general and administrative expenses, stock-based compensation, income taxes, noncontrolling interest in income (loss) of subsidiaries, interest expense, impairment of long-lived assets, other (income) expense, loss (gain) on retirement of debt, gain on sale-leaseback and interest income. Broadcast and digital operating income is not a measure of financial performance under generally accepted accounting principles. Nevertheless, broadcast and digital operating income is a significant measure used by our management to evaluate the operating performance of our core operating segments because broadcast and digital operating income provides helpful information about our results of operations apart from expenses associated with our fixed assets and long-lived intangible assets, income taxes, investments, debt financings and retirements, overhead, stock-based compensation, impairment charges, and asset sales. Our measure of broadcast and digital operating income is similar to industry use of station operating income; however, it reflects our more diverse business and therefore is not completely analogous to “station operating income” or other similarly titled measures used by other companies. Broadcast and digital operating income does not purport to represent operating income or cash flow from operating activities, as those terms are defined under generally accepted accounting principles, and should not be considered as an alternative to those measurements as an indicator of our performance. A reconciliation of net income (loss) to broadcast and digital operating income has been provided in this release.

2              “Adjusted EBITDA” consists of net loss plus (1) depreciation, amortization, income taxes, interest expense, noncontrolling interest in (loss) income of subsidiaries, impairment of long-lived assets, stock-based compensation, (gain) loss on retirement of debt, gain on sale-leaseback, Employment Agreement and incentive plan award expenses and other compensation, contingent consideration from acquisition, severance-related costs, cost investment income, less (2) other income and interest income. Net income before interest income, interest expense, income taxes, depreciation and amortization is commonly referred to in our business as “EBITDA.” Adjusted EBITDA and EBITDA are not measures of financial performance under generally accepted accounting principles. However, we believe Adjusted EBITDA is often a useful measure of a company’s operating performance and is a significant measure used by our management to evaluate the operating performance of our business because Adjusted EBITDA excludes charges for depreciation, amortization and interest expense that have resulted from our acquisitions and debt financing, our taxes, impairment charges, and gain on retirements of debt. Accordingly, we believe that Adjusted EBITDA provides useful information about the operating performance of our business, apart from the expenses associated with our fixed assets and long-lived intangible assets or capital structure. EBITDA is frequently used as one of the measures for comparing businesses in the broadcasting industry, although our measure of Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including, but not limited to the fact that our definition includes the results of all four segments (radio broadcasting, Reach Media, digital and cable television). Adjusted EBITDA and EBITDA do not purport to represent operating income or cash flow from operating activities, as those terms are defined under generally accepted accounting principles, and should not be considered as alternatives to those measurements as an indicator of our performance. A reconciliation of net income (loss) to EBITDA and Adjusted EBITDA has been provided in this release.

3              For the three months ended September 30, 2020 and 2019, Urban One had 44,175,385 and 44,315,077 shares of common stock outstanding on a weighted average basis (basic), respectively. For the nine months ended September 30, 2020 and 2019, Urban One had 44,738,635 and 44,912,673 shares of common stock outstanding on a weighted average basis (basic), respectively. 

4              For the three months ended September 30, 2020 and 2019, Urban One had 44,175,385 and 46,118,702 shares of common stock outstanding on a weighted average basis (fully diluted for outstanding stock awards), respectively. For the nine months ended September 30, 2020 and 2019, Urban One had 44,738,635 and 46,965,245 shares of common stock outstanding on a weighted average basis (fully diluted for outstanding stock awards), respectively.   

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/urban-one-inc-reports-third-quarter-results-301171482.html

SOURCE Urban One, Inc.

Sally Beauty Holdings, Inc. Announces EPS Growth and Positive Same Store Sales for the Fourth Quarter

Sally Beauty Holdings, Inc. Announces EPS Growth and Positive Same Store Sales for the Fourth Quarter

  • GAAP Diluted EPS Grows to $0.62; Increasing 6.9% Compared to Prior Year
  • Adjusted Diluted EPS Grows to $0.63; Increasing 8.6% Compared to Prior Year
  • Positive Same Store Sales Growth of +1.3% for Enterprise; +3.7% for Sally Beauty U.S. and Canada
  • E-commerce Sales Growth Continues: +69% Globally Compared to Prior Year
  • Gross Margin Sees Strong Expansion: Up 150 Basis Points Compared to Prior Year to 51.1%
  • Strong Cash Flow from Operations of $153 Million, Driven by Working Capital Improvements; Operating Free Cash Flow of $131 Million
  • $445 Million of Debt Reduction in Quarter, With Ample Liquidity Remaining; Balance Sheet Cash of $514 Million
  • Agile Reaction to COVID-19 and Continued Transformation Progress Provide Runway for FY21

DENTON, Texas–(BUSINESS WIRE)–Sally Beauty Holdings, Inc. (NYSE: SBH) (“the Company”) today announced financial results for its fourth quarter ended September 30, 2020. The Company will hold a conference call today at 7:30 a.m. Central Time to discuss these results.

Fiscal 2020 Fourth Quarter Overview

For the fourth quarter, consolidated same store sales increased by 1.3%. Consolidated net sales were $957.8 million in the fourth quarter, down 0.8% compared to the prior year, as an increase in same store sales, led by a +3.7% from the Sally Beauty U.S. and Canadian retail business, and a favorable impact from foreign currency translation of approximately 20 basis points on reported sales, was offset by a slower recovery from elements of Beauty Systems Group’s full-service business, the impact of lost professional sales associated with the second round of COVID-19 related shut-downs of California salons during parts of July and August, and a smaller store base with 23 fewer stores compared to the prior year. Global e-commerce sales grew by 69% in the fourth quarter compared to the prior year.

GAAP diluted earnings per share in the fourth quarter were $0.62, compared to $0.58 in the prior year, an increase of 6.9%, driven primarily by a much stronger gross margin rate, lower income tax expense, and a lower average share count; which was partially offset by modestly higher selling, general and administrative expenses due to higher e-commerce delivery expense and continued transformation investment, and an increase in interest expense. Adjusted diluted earnings per share, excluding charges related to the Company’s previously announced restructuring efforts in both years and COVID-19 related income in the current year from a Canadian wage subsidy, were $0.63 in the fourth quarter, compared to $0.58 in the prior year, an increase of 8.6%.

“During the fourth quarter, we saw a significant acceleration in our sales and margin performance compared to the third quarter boosted by the reopening and stabilization of our operations across the globe and progress from our strategic initiatives in innovation, digital content, technology and talent. While total reported sales for the fourth quarter slightly trailed the prior year period, due primarily to the ongoing impact of the COVID crisis and fewer stores, we are pleased to report positive same store sales and significant gross margin expansion. We ended the year with strong liquidity, including $131 million in operating free cash flow for the quarter and a strengthened balance sheet with over $500 million of cash after proactively reducing our debt levels by $445 million. I am proud of our 30,000 associates around the world who assisted our Company in meeting the needs of our customers during this unsettling time,” said Chris Brickman, president and chief executive officer.

“We begin fiscal 2021 focused on completing our transformation plan while maintaining stringent financial discipline and ample liquidity as uncertainty remains as to the duration and severity of the pandemic. Our strategic initiatives will involve capitalizing on strong consumer interest in DIY hair color, building and refining our digital customer experience including the addition of ‘Buy Online / Pickup In-Store’, growing our new Private Label Rewards Credit Card Program, expanding the rollout of JDA to the rest of our distribution centers, and growing our partnerships with Female-owned and Black-owned brands. This should provide our Company with a strong platform as we navigate past COVID-19 and achieve our goal of sustained long-term profitable growth.”

Update on Transformation Plan

Despite the disruptions caused by COVID-19, the Company completed key objectives of our Transformation Plan in Fiscal Year 2020, including:

  • The rollout of the Oracle-based point-of-sale system to both Sally Beauty and Beauty Systems Group stores;
  • The national launch of the new Sally Beauty brand campaign ‘Unleash Your PROtential’;
  • The launch of new service models including ‘Ship-From-Store’ at 2,400 Sally Beauty stores, ‘Same-Day Delivery’ at 1,000 Beauty Systems Group stores and ‘Curbside Pickup’ in both segments;
  • The launch of the new Private Label Rewards Credit Card Program at both Sally Beauty and Beauty Systems Group; and
  • The addition of key talent across store operations, merchandising, marketing, e-commerce and finance.

As we move into Fiscal Year 2021, the Company’s focus will be on the following key initiatives:

  • Leveraging elevated digital capabilities through the rollout of ‘Buy Online / Pickup In-Store’ at all Sally U.S. retail stores in November and expanding it to Beauty Systems Group stores in the second half of the year;
  • Growing customer engagement and loyalty through the recently launched Private Label Rewards Credit Card Program for the Sally Beauty segment and the new Beauty Systems Group loyalty framework, and redesigning of the Beauty Systems Group e-commerce site and mobile app;
  • Increasing brand partnerships that resonate strongly with our customers, including growing our leadership in Female-owned and Black-owned brands;
  • Optimizing efficiencies and driving savings through the ongoing rollout of JDA, our new merchandising and supply chain platform, to all distribution centers; and
  • Continuing to build and refine our digital customer experience, globally.

Fiscal 2020 Fourth Quarter Financial Detail

Consolidated gross profit for the fourth quarter was $489.1 million, an increase of $9.9 million from the prior year. Consolidated gross margin was 51.1%, an increase of 150 basis points compared to the prior year, driven primarily by fewer promotions and favorable mix shifts to higher margin categories, partially offset by a reduction in vendor allowances from fewer promotions and reduced inventory purchases.

As a percentage of sales, selling, general and administrative expenses were 38.3% compared to 37.7% in the prior year, driven primarily by higher e-commerce delivery expense, continued transformation investment, and a lower sales volume compared to the prior year.

GAAP operating earnings and operating margin in the fourth quarter were $119.7 million and 12.5%, respectively, compared to $116.1 million and 12.0%, respectively, in the prior year. Adjusted operating earnings and operating margin were $120.3 million and 12.6%, respectively, compared to $115.3 million and 11.9%, respectively, in the prior year.

GAAP net earnings in the fourth quarter were $70.2 million, an increase of $1.2 million, or 1.7% compared to the prior year. Adjusted EBITDA in the fourth quarter was $146.6million, an increase of $2.5 million, or 1.8%, compared to the prior year, and adjusted EBITDA margin was 15.3%, an increase of 40 basis points compared to the prior year.

During the fourth quarter, cash flow from operations was $152.5million, an increase of 30.8% compared to the prior year, driven in part by working capital improvements. Capital expenditures totaled $21.1million. Operating free cash flow was $131.4million, an increase of 66.6% compared to the prior year.

The Company used cash to reduce its debt levels by $445 million, including paying off its outstanding balance on its revolving line of credit of $375 million, the entire FILO loan balance of $20 million, and $50 million of the fixed portion of its Term Loan B. The Company did not repurchase any shares during the quarter. In addition, the Company also completed a small acquisition in Quebec, Canada, which added 10 stores, 17 direct sales consultants and exclusive distribution rights to premier professional hair color and hair care brands such as Wella Professional, Goldwell and Oribé.

At the end of the fourth quarter, the Company had $514 million in cash on the balance sheet and a zero balance on its $600 million revolving line of credit. Generally, the Company ended the quarter with a leverage ratio of 2.88x, reflecting our significant cash balance. For comparison purposes, the leverage ratio, as defined in our loan agreements, where the impact of cash on-hand is capped at $100 million for net debt calculation purposes, was 3.79x.

Fiscal 2020 Fourth Quarter Segment Results

Sally Beauty Supply

  • Global segment same store sales increased by 1.7% for the fourth quarter. The Sally Beauty businesses in the U.S. and Canada represented 80% of the segment sales for the quarter and had a same store sales increase of 3.7%. Europe had a decrease in same store sales for the quarter while Latin America had a significant decline in same store sales given approximately 15% of the stores were closed for more than half of the quarter due to COVID-19.
  • Net sales were $576.6 million in the quarter, an increase of 0.8% compared to the prior year, driven primarily by the increase in same store sales, a favorable foreign exchange impact of approximately 40 basis points, partially offset by 42 fewer stores compared to the prior year and the temporary store closures in Latin America due to COVID-19.
  • At the end of the quarter, net store count was 3,653, a decline of 42 stores compared to the prior year.
  • Gross margin increased by 180 basis points to 57.6% in the quarter with the Sally Beauty business in the U.S. and Canada hitting a gross margin of 61.0% for the first time. The positive impact from fewer promotions and favorable product mix were partially offset by lower vendor allowances.
  • GAAP operating earnings were $103.9 million in the quarter, an increase of 10.6% compared to the prior year. GAAP operating margin was 18.0%, compared to 16.4% in the prior year.

Beauty Systems Group

  • Total segment same store sales increased by 0.6% for the fourth quarter. The COVID-19 related shut-down of California salons had an unfavorable impact of approximately 90 basis points on the segment’s same store sales.
  • Net sales were $381.2 million in the quarter, a decrease of 3.3% compared to the prior year, driven primarily by a slower recovery from the national account chain business, the impact of lost sales associated with the second round of COVID-19 related shut-downs of California salons during parts of July and August, and an unfavorable foreign exchange impact of approximately 10 basis points.
  • At the end of the quarter, net store count was 1,385, an increase of 19 stores compared to the prior year.
  • Gross margin increased by 60 basis points to 41.2% in the quarter, driven primarily by fewer promotions but partially offset by lower vendor allowances.
  • GAAP operating earnings were $50.6 million in the quarter, a decrease of 14.4% compared to the prior year. GAAP operating margin in the quarter was 13.3%, compared to 15.0% in the prior year.
  • At the end of the quarter, there were 715 distributor sales consultants, compared to 748 in the prior year.

Fiscal 2020 Full-Year Financial Highlights

For the full fiscal year, consolidated same store sales decreased by 8.1%. Consolidated net sales were $3.51 billion, a decrease of 9.3%, driven primarily by the impact of COVID-19 shut-downs, operating 23 fewer stores, and an unfavorable impact from foreign currency translation of approximately 10 basis points. Global e-commerce sales grew by 103% compared to the prior year.

Full-year gross margin was 48.8%, a decrease of 50 basis points compared to the prior year. The primary drivers for the decline were from the non-cash write down of inventory of $27.1 million that occurred in the third quarter and lower vendor allowances from fewer promotions and reduced inventory purchases, which were mostly offset by the benefits of fewer promotions and the favorable mix shift to higher margin categories.

As a percentage of sales, selling, general and administrative expenses were 41.1% compared to 37.5% in the prior year, driven primarily by the significant deleveraging from lost sales related to COVID-19.

GAAP operating earnings and operating margin for the full fiscal year were $258.8 million and 7.4%, respectively, compared to $458.5 million and 11.8%, respectively, in the prior year. Adjusted operating earnings and operating margin, excluding COVID-19 net expenses in the current year and charges related to the Company’s transformation efforts in both years, were $294.4 million and 8.4%, respectively, compared to $457.8 million and 11.8%, respectively, in the prior fiscal year.

GAAP net earnings for the full fiscal year were $113.2 million, a decrease of $158.4 million, or 58.3%, from the prior year. Full-year Adjusted EBITDA was $438.5 million, a decrease of 23.7% from the prior year, and Adjusted EBITDA margin was 12.5%, a decline of approximately 230 basis points from the prior year.

GAAP diluted earnings per share for the full fiscal year were $0.99, a decline of 56.2% compared to the prior year. Adjusted diluted earnings per share in fiscal year 2020 were $1.22, a decline of 46.0% compared to the prior year.

For the full fiscal year, cash flow from operations was $426.9 million, an increase of 33.2% compared to the prior year, driven in part by working capital improvements. Net payments for capital expenditures totaled $110.8 million. Operating free cash flow was $316.1 million, an increase of 38.7% compared to the prior year. For the full fiscal year, the Company repurchased 4.7 million shares at an aggregate cost of $61.4 million.

Fiscal 2020 Full-Year Segment Results

Sally Beauty Supply

  • Global segment same store sales decreased by 8.1% for the full fiscal year, driven primarily by COVID-19 related store shutdowns. The Sally Beauty businesses in the U.S. and Canada represented 80% of the segment sales for the full fiscal year and had a decrease in same store sales of 6.5%.
  • Net sales were $2.08 billion for the full fiscal year, a decrease of 9.3% compared to the prior year, driven primarily by the disruption to business operations from COVID-19, 42 fewer stores, and an unfavorable foreign exchange impact of approximately 20 basis points.
  • Gross margin decreased by 110 basis points to 54.4% for the full fiscal year, driven primarily by the non-cash write down of inventory that occurred in the third quarter, lower vendor allowances from fewer promotions and reduced inventory purchases, which were partially offset by the benefits of fewer promotions and the favorable mix shift to higher margin categories.
  • GAAP operating earnings were $237.6 million for the full fiscal year, a decrease of 35.2% compared to the prior year, driven primarily by the impact from COVID-19. GAAP operating margin was 11.4% compared to 16.0% in the prior year.

Beauty Systems Group

  • Total segment same store sales decreased by 8.3% for the full fiscal year, driven primarily by the impact from COVID-19 related shutdowns.
  • Net sales were $1.43 billion for the full fiscal year, a decrease of 9.5% compared to the prior year, driven primarily by the disruption to business operations from COVID-19 and an unfavorable foreign currency translation impact of approximately 10 basis points.
  • Gross margin increased by 40 basis points at 40.7% for the full fiscal year, driven primarily by fewer promotions, which was partially offset by lower vendor allowances from fewer promotions and reduced inventory purchases.
  • GAAP operating earnings were $194.2 million for the full fiscal year, a decrease of 18.9% compared to the prior year, driven primarily by the impact of COVID-19. GAAP operating margin was 13.5% compared to 15.1% in the prior year.

Fiscal Year 2021 Outlook

The Company will provide perspective on its outlook for the coming quarters during its earnings conference call. The Company will not be providing formal guidance at this time.

Conference Call and Where You Can Find Additional Information

The Company will hold a conference call and audio webcast today to discuss its financial results and its business at approximately 7:30 a.m. Central Time. During the conference call, the Company may discuss and answer one or more questions concerning business and financial matters and trends affecting the Company. The Company’s responses to these questions, as well as other matters discussed during the conference call, may contain or constitute material information that has not been previously disclosed. Simultaneous to the conference call, an audio webcast of the call will be available via a link on the Company’s website, sallybeautyholdings.com/investor-relations. The conference call can be accessed by dialing (844) 867-6169 (International: (409) 207-6975) and referencing the access code 4004457#. The teleconference will be held in a “listen-only” mode for all participants other than the Company’s current sell-side and buy-side investment professionals. In addition, a supplemental slide presentation may be viewed during the call at the following link SBH Q4 Earnings Presentation. A replay of the earnings conference call will be available starting at 10:30 a.m. Central Time, November 12, 2020, through November 19, 2020, by dialing (866) 207-1041 (International: (402) 970-0847 and reference access code 4087901. Also, a website replay will be available on sallybeautyholdings.com/investor-relations.

About Sally Beauty Holdings, Inc.

Sally Beauty Holdings, Inc. (NYSE: SBH) is an international specialty retailer and distributor of professional beauty supplies with revenues of approximately $3.5 billion annually. Through the Sally Beauty Supply and Beauty Systems Group businesses, the Company sells and distributes through 5,038 stores, including 143 franchised units, and has operations throughout the United States, Puerto Rico, Canada, Mexico, Chile, Peru, the United Kingdom, Ireland, Belgium, France, the Netherlands, Spain and Germany. On average, Sally Beauty Supply stores offer about 8,000 products for hair color, hair care, skin care, and nails through proprietary brands such as Ion®, Generic Value Products®, Beyond the Zone® and Silk Elements® as well as professional lines such as Wella®, Clairol®, OPI®, Conair® and Hot Shot Tools®. On average, Beauty Systems Group stores, branded as Cosmo Prof or Armstrong McCall stores, along with its outside sales consultants, sell about 10,500 professionally branded products including Paul Mitchell®, Wella®, Matrix®, Schwarzkopf®, Kenra®, Goldwell®, Joico® and CHI®, intended for use in salons and for resale by salons to retail consumers. For more information about Sally Beauty Holdings, Inc., please visit sallybeautyholdings.com.

Cautionary Notice Regarding Forward-Looking Statements

Statements in this news release and the schedules hereto which are not purely historical facts or which depend upon future events may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, can be identified by the use of forward-looking terminology such as “believes,” “projects,” “expects,” “can,” “may,” “estimates,” “should,” “plans,” “targets,” “intends,” “could,” “will,” “would,” “anticipates,” “potential,” “confident,” “optimistic,” or the negative thereof, or other variations thereon, or comparable terminology, or by discussions of strategy, objectives, estimates, guidance, expectations and future plans. Forward-looking statements can also be identified by the fact these statements do not relate strictly to historical or current matters.

Readers are cautioned not to place undue reliance on forward-looking statements as such statements speak only as of the date they were made. Any forward-looking statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including, but not limited to, the risks and uncertainties related to COVID-19 and those described in our filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K for the year ended September 30, 2019, our Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and our Current Report on Form 8-K dated as of July 30, 2020, each as filed with the Securities and Exchange Commission. Consequently, all forward-looking statements in this release are qualified by the factors, risks and uncertainties contained therein. We assume no obligation to publicly update or revise any forward-looking statements.

Use of Non-GAAP Financial Measures

This news release and the schedules hereto include the following financial measures that have not been calculated in accordance with accounting principles generally accepted in the United States, or GAAP, and are therefore referred to as non-GAAP financial measures: (1) Adjusted EBITDA and EBITDA Margin; (2) Adjusted Operating Earnings and Operating Margin; (3) Adjusted Diluted Net Earnings Per Share; and (4) Operating Free Cash Flow. We have provided definitions below for these non-GAAP financial measures and have provided tables in the schedules hereto to reconcile these non-GAAP financial measures to the comparable GAAP financial measures.

Adjusted EBITDA and EBITDA Margin – We define the measure Adjusted EBITDA as GAAP net earnings before depreciation and amortization, interest expense, income taxes, share-based compensation, costs related to the Company’s previously announced restructuring plans, costs related to COVID-19, costs related to the non-cash write down of inventory related to slow moving SKUs and impairment costs related to long-lived assets not included in restructuring for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures. Adjusted EBITDA Margin is Adjusted EBITDA as a percentage of net sales.

Adjusted Operating Earnings and Operating Margin – Adjusted operating earnings are GAAP operating earnings that exclude costs related to the Company’s previously announced restructuring plans and costs related to COVID-19 for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures. Adjusted Operating Margin is Adjusted Operating Earnings as a percentage of net sales.

Adjusted Diluted Net Earnings Per Share – Adjusted diluted net earnings per share is GAAP diluted earnings per share that exclude tax-effected costs related to the Company’s previously announced restructuring plans and tax-effected costs related to COVID-19 for the relevant time periods as indicated in the accompanying non-GAAP reconciliations to the comparable GAAP financial measures.

Operating Free Cash Flow – We define the measure Operating Free Cash Flow as GAAP net cash provided by operating activities less payments for capital expenditures (net). We believe Operating Free Cash Flow is an important liquidity measure that provides useful information to investors about the amount of cash generated from operations after taking into account payments for capital expenditures (net).

We believe that these non-GAAP financial measures provide valuable information regarding our earnings and business trends by excluding specific items that we believe are not indicative of the ongoing operating results of our businesses; providing a useful way for investors to make a comparison of our performance over time and against other companies in our industry.

We have provided these non-GAAP financial measures as supplemental information to our GAAP financial measures and believe these non-GAAP measures provide investors with additional meaningful financial information regarding our operating performance and cash flows. Our management and Board of Directors also use these non-GAAP measures as supplemental measures to evaluate our businesses and the performance of management, including the determination of performance-based compensation, to make operating and strategic decisions, and to allocate financial resources. We believe that these non-GAAP measures also provide meaningful information for investors and securities analysts to evaluate our historical and prospective financial performance. These non-GAAP measures should not be considered a substitute for or superior to GAAP results. Furthermore, the non-GAAP measures presented by us may not be comparable to similarly titled measures of other companies.

Supplemental Schedules

 

 

Segment Information

1

 

Non-GAAP Financial Measures Reconciliations

2-3

 

Non-GAAP Financial Measures Reconciliations; Adjusted EBITDA and

Operating Free Cash Flow

4

 

Store Count and Same Store Sales

5

 

SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Earnings
(In thousands, except per share data)
(Unaudited)
   
 
Three Months Ended September 30, Twelve Months Ended September 30,

2020

2019

 

Percentage

Change

2020

2019

Percentage

Change

   
Net sales

$ 957,812

$ 965,937

 

(0.8)%

$ 3,514,330

$ 3,876,411

(9.3)%

Cost of products sold

468,669

486,646

 

(3.7)%

1,798,736

1,965,869

(8.5)%

Gross profit

489,143

479,291

 

2.1 %

1,715,594

1,910,542

(10.2)%

Selling, general and administrative expenses

366,982

363,955

 

0.8 %

1,442,809

1,452,751

(0.7)%

Restructuring

2,484

(756)

 

(428.6)%

14,025

(682)

(2156.5)%

Operating earnings

119,677

116,092

 

3.1 %

258,760

458,473

(43.6)%

Interest expense

28,310

22,217

 

27.4 %

98,793

96,309

2.6 %

Earnings before provision for income taxes

91,367

93,875

 

(2.7)%

159,967

362,164

(55.8)%

Provision for income taxes

21,179

24,868

 

(14.8)%

46,722

90,541

(48.4)%

Net earnings

$ 70,188

$ 69,007

 

1.7 %

$ 113,245

$ 271,623

(58.3)%

   
Earnings per share:  
Basic

$0.63

$0.58

 

8.6 %

$0.99

$2.27

(56.4)%

Diluted

$0.62

$0.58

 

6.9 %

$0.99

$2.26

(56.2)%

   
Weighted average shares:  
Basic

112,296

118,374

 

113,881

119,636

Diluted

113,090

118,997

 

114,680

120,283

 

Basis Point

Change

Basis Point

Change

Comparison as a percentage of net sales  
Consolidated gross margin

51.1%

49.6%

 

150

48.8%

49.3%

(50)

Selling, general and administrative expenses

38.3%

37.7%

 

60

41.1%

37.5%

360

Consolidated operating margin

12.5%

12.0%

 

50

7.4%

11.8%

(440)

   
Effective tax rate

23.2%

26.5%

 

(330)

29.2%

25.0%

420

   
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
September 30,

2020

2019

 
Cash and cash equivalents

$ 514,151

$ 71,495

Trade and other accounts receivable

56,429

104,539

Inventory

814,503

952,907

Other current assets

48,014

34,612

Total current assets

1,433,097

1,163,553

Property and equipment, net

315,029

319,628

Operating lease asset

525,634

Goodwill and other intangible assets

598,321

592,837

Other assets

23,066

22,428

Total assets

$ 2,895,147

$ 2,098,446

 
Current maturities of long-term debt

$ 180

$ 1

Accounts payable

236,333

278,688

Accrued liabilities

170,665

169,054

Current operating lease liabilities

153,267

Income taxes payable

2,917

8,336

Total current liabilities

563,362

456,079

Long-term debt

1,796,897

1,594,542

Long-term operating lease liabilities

394,375

Other liabilities

32,976

27,757

Deferred income tax liabilities, net

92,094

80,391

Total liabilities

2,879,704

2,158,769

Total stockholders’ equity (deficit)

15,443

(60,323)

Total liabilities and stockholders’ equity (deficit)

$ 2,895,147

$ 2,098,446

 
Supplemental Schedule 1
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Segment Information
(In thousands)
(Unaudited)
 
 
Three Months Ended September 30, Twelve Months Ended September 30,

 

2020

 

 

2019

 

Percentage

Change

 

2020

 

 

2019

 

Percentage

Change

Net sales:
Sally Beauty Supply (“SBS”)

$

576,578

 

$

571,856

 

0.8

%

$

2,080,703

 

$

2,293,094

 

(9.3

)%

Beauty Systems Group (“BSG”)

 

381,234

 

 

394,081

 

(3.3

)%

 

1,433,627

 

 

1,583,317

 

(9.5

)%

Total net sales

$

957,812

 

$

965,937

 

(0.8

)%

$

3,514,330

 

$

3,876,411

 

(9.3

)%

 
Operating earnings:
SBS

$

103,904

 

$

93,942

 

10.6

%

$

237,588

 

$

366,412

 

(35.2

)%

BSG

 

50,649

 

 

59,172

 

(14.4

)%

 

194,206

 

 

239,572

 

(18.9

)%

Segment operating earnings

 

154,553

 

 

153,114

 

0.9

%

 

431,794

 

 

605,984

 

(28.7

)%

 
Unallocated expenses (1)

 

32,392

 

 

37,778

 

(14.3

)%

 

159,009

 

 

148,193

 

7.3

%

Restructuring

 

2,484

 

 

(756

)

(428.6

)%

 

14,025

 

 

(682

)

(2156.5

)%

Interest expense

 

28,310

 

 

22,217

 

27.4

%

 

98,793

 

 

96,309

 

2.6

%

Earnings before provision for income taxes

$

91,367

 

$

93,875

 

(2.7

)%

$

159,967

 

$

362,164

 

(55.8

)%

 
 
Segment gross margin:

 

2020

 

 

2019

 

Basis Point

Change

 

2020

 

 

2019

 

Basis Point

Change

SBS

 

57.6

%

 

55.8

%

180

 

 

54.4

%

 

55.5

%

(110

)

BSG

 

41.2

%

 

40.6

%

60

 

 

40.7

%

 

40.3

%

40

 

 
Segment operating margin:
SBS

 

18.0

%

 

16.4

%

160

 

 

11.4

%

 

16.0

%

(460

)

BSG

 

13.3

%

 

15.0

%

(170

)

 

13.5

%

 

15.1

%

(160

)

Consolidated operating margin

 

12.5

%

 

12.0

%

50

 

 

7.4

%

 

11.8

%

(440

)

 
 
 
(1) Unallocated expenses, including share-based compensation expense, consist of corporate and shared costs and are included in selling, general and administrative expenses.
Supplemental Schedule 2
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Non-GAAP Financial Measures Reconciliations
(In thousands, except per share data)
(Unaudited)
 
 

Three Months Ended September 30, 2020

As Reported Restructuring (1) COVID-19 (2)

As Adjusted

(Non-GAAP)

 
Selling, general and administrative expenses

$

366,982

 

$

 

$

1,872

 

$

368,854

 

SG&A expenses, as a percentage of sales

 

38.3

%

 

38.5

%

Operating earnings

 

119,677

 

 

2,484

 

 

(1,872

)

 

120,289

 

Operating margin

 

12.5

%

 

12.6

%

Earnings before provision for income taxes

 

91,367

 

 

2,484

 

 

(1,872

)

 

91,979

 

Provision for income taxes (3)

 

21,179

 

 

584

 

 

(502

)

 

21,261

 

Net earnings

$

70,188

 

$

1,900

 

$

(1,370

)

$

70,718

 

 
Earnings per share:
Basic

$

0.63

 

$

0.02

 

$

(0.01

)

$

0.63

 

Diluted

$

0.62

 

$

0.02

 

$

(0.01

)

$

0.63

 

 

Three Months Ended September 30, 2019

As Reported Restructuring (1)

As Adjusted

(Non-GAAP)

 
Selling, general and administrative expenses

$

363,955

 

$

 

$

363,955

 

SG&A expenses, as a percentage of sales

 

37.7

%

 

37.7

%

Operating earnings

 

116,092

 

 

(756

)

 

115,336

 

Operating margin

 

12.0

%

 

11.9

%

Earnings before provision for income taxes

 

93,875

 

 

(756

)

 

93,119

 

Provision for income taxes (3)

 

24,868

 

 

(277

)

 

24,591

 

Net earnings

$

69,007

 

$

(479

)

$

 

$

68,528

 

 
Earnings per share:
Basic

$

0.58

 

$

(0.00

)

$

0.58

 

Diluted

$

0.58

 

$

(0.00

)

$

0.58

 

 
 
 
 
(1) For the three months ended September 30, 2020, restructuring represents expenses incurred primarily in connection with Project Surge and the Transformation Plan. For the three months ended September 30, 2019, restructuring represents a gain in connection with the sale of our Marinette, Wisconsin, fulfillment center, partially offset by expenses incurred in connection with the 2018 Restructuring Plan.
 
(2) COVID-19 primarily represents a wage subsidy provided by the Canadian government under the Canada Emergency Wage Subsidy.
   
(3) The provision for income taxes was calculated using the applicable tax rates for each country, while excluding the tax benefits for countries where the tax benefit is not currently deemed probable of being realized.
Supplemental Schedule 3
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Non-GAAP Financial Measures Reconciliations, Continued
(In thousands, except per share data)
(Unaudited)
 
 
Twelve Months Ended September 30, 2020
As Reported Restructuring (1) COVID-19 (2)

As Adjusted

(Non-GAAP)

 
Selling, general and administrative expenses

$

1,442,809

 

$

 

$

(21,578

)

$

1,421,231

 

SG&A expenses, as a percentage of sales

 

41.1

%

 

40.4

%

Operating earnings

 

258,760

 

 

14,025

 

 

21,578

 

 

294,363

 

Operating margin

 

7.4

%

 

8.4

%

Earnings before provision for income taxes

 

159,967

 

 

14,025

 

 

21,578

 

 

195,570

 

Provision for income taxes (3)

 

46,722

 

 

3,551

 

 

5,183

 

 

55,456

 

Net earnings

$

113,245

 

$

10,474

 

$

16,395

 

$

140,114

 

 
Earnings per share:
Basic

$

0.99

 

$

0.09

 

$

0.14

 

$

1.23

 

Diluted

$

0.99

 

$

0.09

 

$

0.14

 

$

1.22

 

 
Twelve Months Ended September 30, 2019
As Reported Restructuring (1)

As Adjusted

(Non-GAAP)

 
Selling, general and administrative expenses

$

1,452,751

 

$

 

$

1,452,751

 

SG&A expenses, as a percentage of sales

 

37.5

%

 

37.5

%

Operating earnings

 

458,473

 

 

(682

)

 

457,791

 

Operating margin

 

11.8

%

 

11.8

%

Earnings before provision for income taxes

 

362,164

 

 

(682

)

 

361,482

 

Provision for income taxes (3)

 

90,541

 

 

(573

)

 

89,968

 

Net earnings

$

271,623

 

$

(109

)

$

271,514

 

 
Earnings per share:
Basic

$

2.27

 

$

(0.00

)

$

2.27

 

Diluted

$

2.26

 

$

(0.00

)

$

2.26

 

 
 
 
 
(1) For fiscal year 2020, restructuring represents expenses incurred primarily in connection with Project Surge and the Transformation Plan. For fiscal year 2019, restructuring represents gains in connection with the sale of our secondary headquarters and certain fulfillment centers, partially offset by expenses incurred in connection with the 2018 Restructuring Plan.
 
(2) COVID-19 primarily represents costs associated with disaster pay for furloughed employees in response to the coronavirus pandemic. These cost were partially offset by an employee retention payroll tax credit provided by the U.S. Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, and the Canada Emergency Wage Subsidy provided by the Canadian government.
 
(3) The provision for income taxes was calculated using the applicable tax rates for each country upon the recognition of expenses or gains, while excluding the tax benefits for countries where the tax benefit is not currently deemed probable of being realized.
 
Supplemental Schedule 4
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Non-GAAP Financial Measures Reconciliations, Continued
(In thousands)
(Unaudited)
 
 

Three Months Ended September 30,

Twelve Months Ended September 30,

Adjusted EBITDA:

2020

2019

Percentage

Change

2020

2019

Percentage

Change

 
Net earnings

$

70,188

 

$

69,007

 

1.7

%

$

113,245

 

$

271,623

 

(58.3

)%

Add:
Depreciation and amortization

 

25,950

 

 

27,233

 

(4.7

)%

 

106,779

 

 

107,658

 

(0.8

)%

Interest expense

 

28,310

 

 

22,217

 

27.4

%

 

98,793

 

 

96,309

 

2.6

%

Provision for income taxes

 

21,179

 

 

24,868

 

(14.8

)%

 

46,722

 

 

90,541

 

(48.4

)%

EBITDA (non-GAAP)

 

145,627

 

 

143,325

 

1.6

%

 

365,539

 

 

566,131

 

(35.4

)%

Inventory charges (1)

 

 

 

 

 

 

27,054

 

 

 

100.0

%

COVID-19

 

(1,872

)

 

 

100.0

%

 

21,578

 

 

 

100.0

%

Restructuring

 

2,484

 

 

(756

)

(428.6

)%

 

14,025

 

 

(682

)

(2156.5

)%

Share-based compensation

 

(668

)

 

1,452

 

(146.0

)%

 

8,426

 

 

9,180

 

(8.2

)%

Impairment (2)

 

982

 

 

 

100.0

%

 

1,883

 

 

 

100.0

%

Adjusted EBITDA (non-GAAP)

$

146,553

 

$

144,021

 

1.8

%

$

438,505

 

$

574,629

 

(23.7

)%

 

Basis Point

Change

Basis Point

Change

Adjusted EBITDA as a percentage of net sales
Adjusted EBITDA margin

 

15.3

%

 

14.9

%

40

 

 

12.5

%

 

14.8

%

(230

)

 
 
Operating Free Cash Flow:

2020

2019

Percentage

Change

2020

2019

Percentage

Change

Net cash provided by operating activities

$

152,505

 

$

116,592

 

30.8

%

$

426,889

 

$

320,415

 

33.2

%

Less:
Payments for property and equipment, net (3)

 

21,103

 

 

37,701

 

(44.0

)%

 

110,805

 

 

92,443

 

19.9

%

Operating free cash flow (non-GAAP)

$

131,402

 

$

78,891

 

66.6

%

$

316,084

 

$

227,972

 

38.7

%

 
(1) Incremental, non-cash write down of inventory as part of aggressive tactical inventory clearance actions.
 
(2) Impairment charges related to long-lived assets and operating lease assets outside of restructuring.
 
(3) For the three and twelve months ended September 30, 2019, payments for property and equipment, net includes cash proceeds of $3.3 million and $15.3 million, respectively, from the sale of our secondary headquarters and certain fulfillment centers in connection with the Transformation Plan.
Supplemental Schedule 5
 
SALLY BEAUTY HOLDINGS, INC. AND SUBSIDIARIES
Store Count and Same Store Sales
(Unaudited)
 
 
As of September 30,

2020

2019

Change

 
Number of stores:
SBS:
Company-operated stores

3,644

 

3,682

 

(38

)

Franchise stores

9

 

13

 

(4

)

Total SBS

3,653

 

3,695

 

(42

)

BSG:
Company-operated stores

1,251

 

1,220

 

31

 

Franchise stores

134

 

146

 

(12

)

Total BSG

1,385

 

1,366

 

19

 

Total consolidated

5,038

 

5,061

 

(23

)

 
Number of BSG distributor sales consultants

715

 

748

 

(33

)

 
BSG distributor sales consultants (DSC) include 183 and 202 sales consultants employed by our franchisees at September 30, 2020 and 2019, respectively. Additionally, the DSC count at September 30, 2020 includes 17 new DSCs in connection with a BSG acquisition.
Three Months Ended September 30, Twelve Months Ended September 30,

2020

2019

 

Basis Point

Change

2020

2019

Basis Point

Change

Same store sales growth (decline):
SBS

1.7

%

1.3

%

40

 

(8.1

)%

0.4

%

(850

)

BSG

0.6

%

0.8

%

(20

)

(8.3

)%

0.2

%

(850

)

Consolidated

1.3

%

1.1

%

20

 

(8.1

)%

0.3

%

(840

)

 
 
For the purpose of calculating our same store sales metrics, we compare the current period sales for stores open for 14 months or longer as of the last day of a month with the sales for these stores for the comparable period in the prior fiscal year. Our same store sales are calculated in constant U.S. dollars and include e-commerce sales, but do not generally include the sales from stores relocated until 14 months after the relocation. The sales from stores acquired are excluded from our same store sales calculation until 14 months after the acquisition.

 

Jeff Harkins

Investor Relations

940-297-3877

KEYWORDS: Texas United States North America

INDUSTRY KEYWORDS: Discount/Variety Women Other Retail Specialty Fashion Cosmetics Consumer Retail Online Retail

MEDIA:

Logo
Logo

SQZ Biotech to Present at November Virtual Investor Conferences

SQZ Biotech to Present at November Virtual Investor Conferences

WATERTOWN, Mass.–(BUSINESS WIRE)–
SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD, chief executive officer of SQZ, and additional management will participate in the following upcoming virtual investor conferences:

Stifel 2020 Virtual Healthcare Conference

Tuesday, November 17, 2020

Presentation Time: 1:20 pm EST

Webcast available

Jefferies Virtual London Healthcare Conference

Thursday, November 19, 2020

Presentation Time: 7:55 am EST/12:55 pm GMT

Webcast available

The live webcast of SQZ’s presentations can also be accessed through the “Events & Presentations” page within the Investors & Media section of the SQZ website. Replays of the webcast will be available on the SQZ website for 90 days following the event.

About SQZ Biotech

SQZ Biotech is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the unique ability to deliver multiple materials into many patient cell types to engineer what we believe to be an unprecedented range of potential therapeutics for a range of diseases. SQZ has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays. Our goal is to use the SQZ approach to establish a new paradigm for cell therapies. The first therapeutic applications leverage SQZ’s ability to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases. For more information please visit www.sqzbiotech.com.

Forward Looking Statement

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained that do not relate to matters of historical fact should be considered forward-looking statements, including statements relating to upcoming events and presentations, our product candidates, preclinical or clinical trial timing, and preclinical or clinical data or results. These forward-looking statements are based on management’s current expectations. The words ”may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “estimate,” “believe,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

These and other important factors discussed under the caption “Risk Factors” in our Form S-1 filed with the U.S. Securities and Exchange Commission (SEC) on October 26, 2020 and our other filings with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements. Any forward-looking statements represent management’s estimates as of this date. New risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. While we may elect to update forward-looking statements in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Although we believe the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

Certain information contained in this press release relates to or is based on studies, publications, surveys and other data obtained from third-party sources and our own internal estimates and research. While we believe these third-party sources to be reliable as of the date of this press release, we have not independently verified, and we make no representation as to the adequacy, fairness, accuracy or completeness of any information obtained from third-party sources.

SQZ IR Contact:

Rebecca Cohen

Corporate and Investor Relations

[email protected]

617-758-8672 ext. 728

Media Contact:

Kate Contreras

[email protected]

617-229-5960

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo

Express, Inc. Announces Earnings Release Date, Conference Call and Webcast for Third Quarter 2020 Results

Express, Inc. Announces Earnings Release Date, Conference Call and Webcast for Third Quarter 2020 Results

COLUMBUS, Ohio–(BUSINESS WIRE)–
Fashion apparel retailer Express, Inc. (NYSE: EXPR) today announced that it will conduct a conference call to discuss third quarter 2020 results on Thursday, December 3, 2020 at 8:30 a.m. Eastern Time (ET). Earlier that morning, the Company will issue a press release detailing those results. The conference call will be hosted by Tim Baxter, Chief Executive Officer, and Perry Pericleous, Senior Vice President and Chief Financial Officer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201112005078/en/

Express storefront at Easton Town Center in Columbus, Ohio. (Photo: Business Wire)

Express storefront at Easton Town Center in Columbus, Ohio. (Photo: Business Wire)

Investors and analysts interested in participating in the call are invited to dial (877) 683-0508 approximately ten minutes prior to the start of the call. The conference call will also be webcast live at http://www.express.com/investor and remain available for 90 days. A telephone replay of this call will be available at 12:00 p.m. ET on December 3, 2020 until 11:59 p.m. ET on December 10, 2020 and can be accessed by dialing (800) 585-8367 and entering the replay pin number 8242308. In addition, an investor presentation of third quarter 2020 results will be available at http://www.express.com/investor at approximately 7:00 a.m. ET on December 3, 2020.

About Express, Inc.:

Express is a modern, versatile, dual gender apparel and accessories brand that helps people get dressed for every day and any occasion. Launched in 1980 with the idea that style, quality and value should all be found in one place, Express has always been a brand of the now, offering some of the most important and enduring fashion trends. Express aims to Create Confidence & Inspire Self-Expression through a design & merchandising view that brings forward The Best of Now for Real Life Versatility.

The company operates over 500 retail and factory outlet stores in the United States and Puerto Rico, as well as an online store. Express, Inc. is traded on the NYSE under the symbol EXPR. For more information, please visit www.express.com.

Investor Contact:

Dan Aldridge

[email protected]

(614) 474-4890

Media Contact:

Alysa Spittle

[email protected]

(614) 474-4745

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Men Online Retail Other Retail Family Discount/Variety Specialty Consumer Fashion Teens Retail Other Consumer Women

MEDIA:

Photo
Photo
Express storefront at Easton Town Center in Columbus, Ohio. (Photo: Business Wire)

TCR² Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

– Consistent progress of TC-210 with interim update from Phase 1/2 trial anticipated in 4Q20

– Additional clinical sites to include UCSF Medical Center and Princess Margaret Cancer Centre in the TC-210 Phase 1/2 clinical trial

– Agreement with ElevateBio for additional manufacturing capacity for production of TC-210 Phase 2 clinical trial material

CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced financial results for the third quarter ended September 30, 2020 and provided a corporate update.

“The third quarter was marked by consistency in the clinical benefit provided by our lead TRuC-T cell program, TC-210, previously shown to have produced RECIST partial responses at its very first dose level, as well as the completion of a successful financing,” said Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics. “As we prepare for the expansion portion of the TC-210 trial, we are excited to bring on additional clinical sites to increase patient recruitment and we have also launched a strategic partnership with ElevateBio, whose state-of-the-art manufacturing center will support the Phase 2 clinical trial of TC-210 and planned investigator-initiated studies. We look forward to providing a clinical data update on TC-210 in the fourth quarter.”

Recent Developments

  • TCR2 announced a partnership with ElevateBio, LLC, a Cambridge, MA-based creator and operator of a portfolio of innovative cell and gene therapy companies. The agreement with ElevateBio provides TCR2 access to ElevateBio BaseCamp, its centralized 140,000 square foot, world-class cell and gene therapy manufacturing facility based in Waltham, MA. The BaseCamp partnership enables TCR2 Therapeutics to establish additional manufacturing capacity and technical capabilities in the U.S., in addition to its existing Stevenage, UK, manufacturing facility, and will support the Phase 2 expansion portion of the TC-210 Phase 1/2 clinical trial once a recommended Phase 2 dose is defined.

Anticipated Milestones

  • TCR2 anticipates an interim update from the Phase 1 portion of the TC-210 Phase 1/2 clinical trial for patients with mesothelin-expressing solid tumors in 4Q20.
  • TCR2 anticipates an interim update from the Phase 1 portion of the TC-110 Phase 1/2 clinical trial for patients with CD19+ non-Hodgkin lymphoma or adult acute lymphoblastic leukemia in 2021.
  • TCR2 anticipates certification of its manufacturing facility in Stevenage, UK, in 4Q20.
  • TCR2 anticipates an IND filing for a third TRuC-T cell program in 2021.

Financial Highlights

  • Cash Position: TCR2 ended the third quarter of 2020 with $246.7 million in cash, cash equivalents, and investments compared to $158.1 million as of December 31, 2019. Net cash used in operations was $10.8 million for the third quarter of 2020 compared to $10.1 million for third quarter of 2019. TCR2 projects net cash use of $65-70 million for 2020.

  • R&D Expenses: Research and development expenses were $12.8 million for the third quarter of 2020 compared to $11.3 million for the third quarter of 2019. The increase in R&D expenses were primarily related to increases in headcount, activities related to the Phase 1/2 clinical trial of TC-210 and activities related to the Phase 1/2 clinical trial of TC-110.

  • G&A Expenses: General and administrative expenses were $4.4 million for the third quarter of 2020 compared to $3.5 million for the third quarter of 2019. The increase in general and administrative expenses was primarily due to an increase in personnel costs and costs associated with operations as a public company.

  • Net Loss: Net loss was $16.9 million for the third quarter of 2020 compared to $13.8 million for the third quarter of 2019, driven predominantly by increased personnel expenses.

Upcoming Events

TCR2 Therapeutics management is scheduled to participate at the following upcoming conferences.

  • Jefferies Virtual London Healthcare Conference: Garry Menzel, Ph.D., President and Chief Executive Officer of TCR2 Therapeutics, will provide a company update using a virtual platform on Wednesday, November 18, 2020 at 9:40am ET
  • Piper Sandler 32nd Annual Virtual Healthcare Conference: Ian Somaiya, Chief Financial Officer of TCR2 Therapeutics, and Alfonso Quintás Cardama, M.D., Chief Medical Officer of TCR2 Therapeutics, will participate in a fireside chat using a virtual platform on Monday, November 23, 2020 at 10:00am ET

Forward-looking Statements

This press release contains forward-looking statements and information within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. The use of words such as “may,” “will,” “could”, “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “seeks,” “endeavor,” “potential,” “continue” or the negative of such words or other similar expressions can be used to identify forward-looking statements. These forward-looking statements include, but are not limited to, express or implied statements regarding the therapeutic potential of TC-210, timing for interim updates for the TC-210 and TC-110 clinical trials, timing for the certification of our manufacturing facility in Stevenage, UK, increased manufacturing capacity and technical capabilities, including relating to our manufacturing partnership with ElevateBio, LLC, increased clinical trial demand, future IND filings and clinical development plans, the development of the Company’s TRuC-T cells, their potential characteristics, applications and clinical utility, and the potential therapeutic applications of the Company’s TRuC-T cell platform.

The expressed or implied forward-looking statements included in this press release are only predictions and are subject to a number of risks, uncertainties and assumptions, including, without limitation: uncertainties inherent in clinical studies and in the availability and timing of data from ongoing clinical studies; whether interim results from a clinical trial will be predictive of the final results of the trial; whether results from preclinical studies or earlier clinical studies will be predictive of the results of future trials; the expected timing of submissions for regulatory approval or review by governmental authorities, including review under accelerated approval processes; orphan drug designation eligibility; regulatory approvals to conduct trials or to market products; TCR2’s ability to maintain sufficient manufacturing capabilities to support its research, development and commercialization efforts, including TCR2’s ability to secure additional manufacturing facilities; whether TCR2‘s cash resources will be sufficient to fund TCR2‘s foreseeable and unforeseeable operating expenses and capital expenditure requirements, the impact of the COVID-19 pandemic on TCR2’s ongoing operations; and other risks set forth under the caption “Risk Factors” in TCR2’s most recent Annual Report on Form 10-K, most recent Quarterly Report on Form 10-Q and its other filings with the Securities and Exchange Commission. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although TCR2 believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur.

Moreover, except as required by law, neither TCR2 nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements included in this press release. Any forward-looking statement included in this press release speaks only as of the date on which it was made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

About TCR

2

Therapeutics

TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors or hematological malignancies. TCR2’s proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells) specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). In preclinical studies, TRuC-T cells have demonstrated superior anti-tumor activity compared to chimeric antigen receptor T cells (CAR-T cells), while secreting lower levels of cytokine release. The Company’s lead TRuC-T cell product candidate targeting solid tumors, TC-210, is currently being studied in a Phase 1/2 clinical trial to treat patients with mesothelin-positive non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. The Company’s lead TRuC-T cell product candidate targeting hematological malignancies, TC-110, is currently being studied in a Phase 1/2 clinical trial to treat patients with CD19-positive adult acute lymphoblastic leukemia (aALL) and with aggressive or indolent non-Hodgkin lymphoma (NHL). For more information about TCR2, please visit www.tcr2.com.

Investor and Media Contact:

Carl Mauch
Director, Investor Relations and Corporate Communications
TCR2 Therapeutics Inc.
(617) 949-5667
[email protected]

TCR

2

THERAPEUTICS INC.

UNAUDITED CONSOLIDA
TED BALANCE SHEETS

(amounts in thousands, except share data)

    September
 
30, 2020
  December
 
31, 2019
 
Assets              
Current assets              
Cash and cash equivalents   $ 101,614   $ 65,296  
Investments     145,109     92,828  
Prepaid expenses and other current assets     7,509     5,061  
Total current assets     254,232     163,185  
               
Property and equipment, net     6,201     4,926  
Restricted cash     417     417  
Deferred offering costs          
Total assets   $ 260,850   $ 168,528  
               
Liabilities and stockholders

equity
             
Accounts payable   $ 2,948   $ 2,483  
Accrued expenses and other current liabilities     4,904     5,050  
Total current liabilities     7,852     7,533  
               
Other liabilities     635     546  
Total liabilities     8,487     8,079  
               
Stockholders’ equity              
Common stock, $0.0001 par value; 150,000,000 shares authorized; 33,397,669 and 24,050,936 shares issued; 33,380,211 and 23,981,109 shares outstanding at September 30, 2020 and December 31, 2019, respectively.     3     2  
Additional paid-in capital     483,433     342,896  
Accumulated other comprehensive income     191     142  
Accumulated deficit     (231,264 )   (182,591 )
Total stockholders’ equity     252,363     160,449  
Total liabilities and stockholders’ equity   $ 260,850   $ 168,528  

TCR

2

THERAPEUTICS INC.

UNAUDITED CONSOLIDATED S
TATEMENTS OF OPERATIONS

(amounts in thousands, except share and per share data)

    Three Months Ended

September
 
30,
    Nine Months Ended

September
 
30,
 
    2020     2019     2020     2019  
Operating expenses                                
Research and development   $ 12,820     $ 11,374     $ 37,682     $ 28,096  
General and administrative     4,371       3,522       12,451       9,715  
Total operating expenses     17,191       14,896       50,133       37,811  
Loss from operations     (17,191 )     (14,896 )     (50,133 )     (37,811 )
                                 
Interest income, net     300       1,090       1,546       3,039  
Loss before income taxes     (16,891 )     (13,806 )     (48,587 )     (34,772 )
                                 
Income taxes     31             86        
Net loss     (16,922 )     (13,806 )     (48,673 )     (34,772 )
                                 
Accretion of redeemable convertible preferred stock to redemption value                     $ (49,900 )
Net loss attributable to common stockholders   $ (16,922 )   $ (13,806 )   $ (48,673 )   $ (84,672 )
                                 
Per share information                                
Net loss per share of common stock, basic and diluted   $ (0.56 )   $ (0.58 )   $ (1.86 )   $ (4.21 )
                                 
Weighted average shares outstanding, basic and diluted     30,340,355       23,874,593       26,158,040       20,125,955  

TCR

2

THERAPEUTICS INC.

UNAUDITED CONSOLIDATED S
TATEMENTS OF CASH FLOWS

(amounts in thousands)

  Nine Months Ended September
 
30,
 
  2020     2019  
Operating activities              
Net loss $ (48,673 )   $ (34,772 )
Adjustments to reconcile net loss to cash used in operating activities:              
Depreciation and amortization   1,114       558  
Stock-based compensation expense   6,186       4,597  
Deferred tax liabilities   86        
Changes in operating assets and liabilities:              
Prepaid expenses and other current assets   (2,449 )     (3,615 )
Accounts payable   610       489  
Accrued expenses and other liabilities   (114 )     1,697  
Cash used in operating activities   (43,240 )     (31,046 )
               
Investing activities              
Purchases of equipment   (2,523 )     (3,060 )
Purchases of investments   (162,147 )     (126,534 )
Proceeds from sale or maturity of investments   109,916       82,990  
Cash used in investing activities   (54,754 )     (46,604 )
               
Financing activities              
Proceeds from public offering of common stock, net of issuance costs   133,570       79,121  
Proceeds from the exercise of stock options   742       299  
Cash provided by financing activities   134,312       79,420  
               
Net change in cash, cash equivalents, and restricted cash   36,318       1,770  
Cash, cash equivalents, and restricted cash at beginning of year   65,713       47,964  
Cash, cash equivalents, and restricted cash at end of period $ 102,031     $ 49,734  

Annovis Bio Reports Positive Results from Final Phase of $1.9M NIH Funded Chronic Toxicology Study for its Lead Compound for the Treatment of Alzheimer’s and Parkinson’s Diseases

BERWYN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced it successfully completed the dog cohort of a chronic toxicology study of its lead therapeutic compound ANVS401 for the treatment of AD and PD, reporting no negative side effects.

The nine-month dog study was part of a series of animal toxicology studies, funded by a $1.9 million grant from the National Institutes of Health that began in the fourth quarter of 2019. The strong safety data corroborates the positive results from the Company’s prior one-month safety studies in mice, rats, dogs, and humans and six-month study in rats.   

Maria Maccecchini, Ph.D., CEO, commented, “The strong safety profile observed in ANVS401 in our chronic tox study in dogs is another important milestone for Annovis. Our chronic toxicology studies, which are key to enabling us to conduct long-term human studies, provide a solid foundation for ANVS401 as we continue to recruit and treat patients for our two active Phase 2a clinical trials. We intend to report interim data on our Phase 2a clinical trials in the first quarter of 2021.”

About
Annovis
Bio

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Alzheimer’s in Down Syndrome (AD-DS). We believe that we are the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. We expect our treatment to improve memory loss and dementia associated with AD and AD-DS, as well as body and brain function in PD. We have an ongoing Phase 2a study in AD patients and have commenced a second Phase 2a study in AD and PD patients. For more information on Annovis, please visit the company’s website: www.annovisbio.com.

Forward-Looking Statements

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “expect,” “believe,” “will,” “may,” “should,” “estimate,” “project,” “outlook,” “forecast” or other similar words, and include, without limitation, statements regarding the timing, effectiveness and anticipated results of ANVS401 clinical trials. Forward-looking statements are based on Annovis Bio, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate, including that clinical trials may be delayed. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Annovis Bio, Inc. undertakes no duty to update such information except as required under applicable law.

Investor Relations:

Dave Gentry, CEO
RedChip Companies Inc.
407-491-4498
[email protected]

SOURCE: Annovis Bio, Inc.

Energizer Holdings, Inc. Announces CEO Succession

– Alan R. Hoskins to Retire as CEO in January 2021

– Board Elects Mark S. LaVigne as Successor

PR Newswire

ST. LOUIS, Nov. 12, 2020 /PRNewswire/ — Energizer Holdings, Inc. (NYSE: ENR) (the “company”) today announced that Alan R. Hoskins has informed the company’s Board of Directors of his decision to retire as Chief Executive Officer, effective January 1, 2021. The Board has elected Mark S. LaVigne, President and Chief Operating Officer of Energizer, to succeed Mr. Hoskins as the company’s next CEO. Mr. Hoskins will continue to serve as a Director, upon election at the 2021 Annual Shareholders’ Meeting, and as an advisor to the company until September 30, 2021. The Board intends to nominate Mr. LaVigne to stand for election as a Director at the 2021 Annual Shareholders’ Meeting.  

“Alan is an exceptional leader who has guided Energizer through an extraordinary transformation into a stand-alone public company and a global consumer products leader with a strong foundation for long-term success,” said Pat Moore, independent Chairman of the Board. “He has had a notable nearly four-decade-long career at our company, and during his time as CEO, has led the Energizer team through two strategic acquisitions and in building enduring brands, a global infrastructure and strong supplier and customer relationships. With his relentless focus on innovation, operations and people, Alan has helped develop a talented leadership team that is focused on delivering on Energizer’s strategic priorities. I’m pleased that he will remain as a Director and an advisor to the company through September to help ensure a smooth transition while he turns towards his personal philanthropic activities.”

Mr. Hoskins commented, “Like many people, over the past several months, I have had the opportunity to reflect on my life, my future and what is most important to me. After a fulfilling career at Energizer spanning nearly 40 years, including the last five as CEO, I determined in conjunction with the Board that now is the right time for Energizer to transition to new leadership. Mark’s capabilities and deep understanding of Energizer’s diverse markets, operations and colleagues make him uniquely qualified to lead Energizer into its next phase of growth. As I enter my next chapter, I look forward to spending more time with my family and pursuing philanthropic opportunities. I would like to thank all of our colleagues for their dedication and efforts in positioning Energizer as the leader in consumer products that it is today, especially through the recent challenges of the pandemic, and I am certain that Mark and the rest of the executive team will continue the company’s momentum for many years to come.”

Mr. Moore continued, “Mark’s appointment is the culmination of rigorous succession planning by the Board and we have great confidence that he will be an excellent CEO for Energizer. Mark is an outstanding executive who has helped define and execute Energizer’s strategic initiatives and has overseen the company’s integrated operating model with a focus on growing its platform and market positions in the Batteries, Lights and Auto Care categories. Through his time this past year serving as President and COO, along with his previous roles at Energizer and outside our organization, Mark brings strong leadership skills and expertise that will serve the company well into the future.”

“I am honored to take on the role of CEO and lead Energizer and its dedicated colleagues around the world,” said Mr. LaVigne. “Despite the unprecedented challenges of this year, our long-term strategies remain intact, and we are well-positioned to strengthen our leadership across categories and generate sustainable growth. We recognize we have hurdles to overcome, but I have complete confidence in our organization and am tremendously excited about Energizer’s future prospects. I thank Alan for his leadership and collaboration and look forward to working with him to ensure a seamless transition.”

Mr. Hoskins’ retirement concludes a remarkable, nearly four-decade-long career with Energizer, including serving as CEO since 2015. He has played a key role in the company’s growth and transformation, establishing Energizer as a standalone public company and defining its strategic priorities – leading with innovation, operating with excellence and driving productivity – as well as overseeing the company’s two transformational acquisitions of Spectrum Brands’ battery and portable lighting and global auto care businesses. Over the course of Mr. Hoskins’ tenure, Energizer has transformed into a leading global consumer products company and is now the global value share leader in the battery and auto care categories and the branded share leader in the portable lighting category. Mr. Hoskins’ focus on talent and culture as the key drivers of the company’s success has empowered colleagues to take control, drive significant change and deliver on commitments, as well as instilled diversity as a key value across the organization, with almost half of the Company’s critical roles now held by women and people of color. As a result of these efforts, Energizer has delivered strong financial results under Mr. Hoskins’ leadership, including five consecutive years of organic sales growth and significant Net Sales, Adjusted EBITDA and Adjusted Free Cash flow growth over the same timeframe, and is well positioned to generate long-term shareholder value for years to come.

Fourth Quarter and Fiscal Year 2020 Results

The company also announced today in a separate press release its fourth quarter and fiscal year 2020 results. The webcast is scheduled to begin at 10:00 a.m. ET and can be accessed at www.energizerholdings.com, under the “Investors” and “Events and Presentations” tabs. A replay of the webcast will be available on the company’s website.

About Energizer Holdings, Inc.

Energizer Holdings, Inc. (NYSE: ENR), headquartered in St. Louis, Missouri, is one of the world’s largest manufacturers and distributors of primary batteries, portable lights, and auto care appearance, performance, refrigerant, and fragrance products. Our portfolio of globally recognized brands include Energizer®, Armor All®, Eveready®, Rayovac®, STP®, Varta®, A/C Pro®, Refresh Your Car! ®, California Scents®, Driven®, Bahama & Co. ®, LEXOL®, Eagle One®, Nu Finish®, Scratch Doctor®, and Tuff Stuff®. As a global branded consumer products company, Energizer’s mission is to lead the charge to deliver value to our customers and consumers better than anyone else.

Forward-Looking Statements

Certain information contained in this news release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future results or performance and involve certain risks, uncertainties and assumptions difficult to predict or beyond our control. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “Commission”) on November 19, 2019 and subsequent Commission filings. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update any forward-looking statement to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made. 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/energizer-holdings-inc-announces-ceo-succession-301171662.html

SOURCE Energizer Holdings, Inc.

Multifamily Portfolio in Hollywood, Los Angeles Trades Hands, Sale Facilitated by Walker & Dunlop

PR Newswire

BETHESDA, Md., Nov. 12, 2020 /PRNewswire/ — Walker & Dunlop, Inc. announced today that it completed the sale of Argyle & Harvard Apartments, a two-property, 98-unit value-add portfolio. Situated in the Hollywood submarket of Los Angeles, California, the unofficial global headquarters for the entertainment and media industry, the multifamily communities offer immediate access to Hollywood’s expanding corporate footprint and growing job base. It is estimated that over 566,000 jobs exist throughout neighboring submarkets, which include notable employers such as Netflix, HBO, ViacomCBS, and Showtime, as well as rapidly growing digital media startups.

Built in 1970 and 1955 respectively, Argyle & Harvard Apartments presents new ownership with the opportunity to significantly increase rental income. Enhancing finishes in the 21 lightly-renovated units, as well as fully renovating the 77 units that are in original condition, could result in an almost 44 percent increase in rents.

Walker & Dunlop’s Blake Rogers, Alexandra Caniglia, Hunter Combs, Javier Rivera, and Kevin Sheehan represented the seller and facilitated the sale of the portfolio.

The transaction is one of just seven multifamily property sales with 50+ units in the City of Los Angeles since the Covid-19 pandemic started; this represents more than a 50 percent decrease in transaction volume compared to the past several years1.

The Southern California Walker & Dunlop team has closed more than $325,000,000 in multifamily sales transactions over the past 30 days. Nationally, the Walker & Dunlop investment sales platform has also achieved dramatic growth with over $4 billion in sales volume completed through 3Q 2020 in the face of the pandemic. Walker & Dunlop is a top-ranked commercial real estate finance company; in 2019, the firm completed $32.0 billion in total transaction volume, and was ranked the #1 Fannie Mae DUS® multifamily lender and the #3 Freddie Mac Optigo® lender by volume.

For information about Walker & Dunlop’s view on the apartment market, including expert perspectives on markets, leadership, and the road ahead, visit our Driven by Insight information center.

About Walker & Dunlop

Walker & Dunlop (NYSE: WD), headquartered in Bethesda, Maryland, is one of the largest commercial real estate finance companies in the United States. The company provides a comprehensive range of capital solutions for all commercial real estate asset classes, as well as investment sales brokerage services to owners of multifamily properties. Walker & Dunlop is included on the S&P SmallCap 600 Index and was ranked as one of FORTUNE Magazine’s Fastest Growing Companies in 2014, 2017, and 2018. Walker & Dunlop’s 900+ professionals in 40 offices across the nation have an unyielding commitment to client satisfaction.

1CoStar

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/multifamily-portfolio-in-hollywood-los-angeles-trades-hands-sale-facilitated-by-walker–dunlop-301171448.html

SOURCE Walker & Dunlop, Inc.